| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.687 | 0.005 | 0.687 | MAP kinase 1 inhibitor | 0.5 0.054 DBMET03717 0.608 0.018 DBMET03709 0.596 0.021 DBMET03713 0.581 0.025 DBMET03715 0.67 0.007 DBMET03718 0.488 0.058 DBMET03710 0.449 0.078 DBMET03712 0.471 0.066 DBMET03711 0.642 0.012 DBMET03719 | ||
| 0.627 | 0.009 | 0.7 | Tyrosine kinase inhibitor | 0.298 0.043 DBMET03717 0.527 0.015 DBMET03709 0.367 0.032 DBMET03713 0.422 0.025 DBMET03715 0.519 0.016 DBMET03718 0.611 0.01 DBMET03710 0.335 0.037 DBMET03712 0.271 0.049 DBMET03711 0.7 0.006 DBMET03719 | DBMET03719 | |
| 0.501 | 0.033 | 0.592 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.358 0.142 DBMET03717 0.429 0.076 DBMET03709 0.447 0.063 DBMET03714 0.592 0.008 DBMET03713 0.561 0.013 DBMET03715 0.416 0.087 DBMET03718 0.511 0.029 DBMET03710 0.497 0.035 DBMET03712 0.532 0.021 DBMET03711 0.454 0.059 DBMET03719 | DBMET03713 | |
| 0.476 | 0.025 | 0.485 | MAP kinase kinase 6 inhibitor | 0.342 0.099 DBMET03717 0.436 0.04 DBMET03709 0.343 0.098 DBMET03714 0.47 0.027 DBMET03713 0.429 0.043 DBMET03715 0.409 0.053 DBMET03718 0.485 0.022 DBMET03710 0.386 0.067 DBMET03712 0.425 0.045 DBMET03711 0.476 0.025 DBMET03719 | DBMET03710 | |
| 0.447 | 0.012 | 0.541 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.332 0.033 DBMET03717 0.387 0.02 DBMET03709 0.312 0.04 DBMET03714 0.428 0.014 DBMET03713 0.404 0.017 DBMET03715 0.446 0.012 DBMET03718 0.509 0.008 DBMET03710 0.35 0.028 DBMET03712 0.362 0.025 DBMET03711 0.541 0.006 DBMET03719 | DBMET03719 | |
| 0.357 | 0.003 | 0.742 | Cathepsin L2 inhibitor | 0.356 0.003 DBMET03717 0.335 0.003 DBMET03709 0.742 0.001 DBMET03714 0.353 0.003 DBMET03718 0.393 0.003 DBMET03719 | DBMET03714 | |
| 0.36 | 0.008 | 0.454 | MAP kinase 9 inhibitor | 0.177 0.028 DBMET03717 0.267 0.014 DBMET03709 0.241 0.017 DBMET03713 0.234 0.017 DBMET03715 0.334 0.009 DBMET03718 0.313 0.011 DBMET03710 0.169 0.03 DBMET03712 0.164 0.032 DBMET03711 0.454 0.005 DBMET03719 | DBMET03719 | |
| 0.367 | 0.017 | 0.504 | MAP kinase kinase 2 inhibitor | 0.239 0.059 DBMET03717 0.271 0.045 DBMET03709 0.286 0.04 DBMET03714 0.279 0.043 DBMET03713 0.324 0.028 DBMET03715 0.459 0.006 DBMET03718 0.364 0.018 DBMET03710 0.222 0.069 DBMET03712 0.178 0.097 DBMET03711 0.504 0.005 DBMET03719 | DBMET03719 | |
| 0.36 | 0.011 | 0.455 | Lck kinase inhibitor | 0.246 0.025 DBMET03717 0.281 0.019 DBMET03709 0.358 0.011 DBMET03713 0.332 0.013 DBMET03715 0.339 0.013 DBMET03718 0.414 0.007 DBMET03710 0.26 0.022 DBMET03712 0.265 0.021 DBMET03711 0.455 0.005 DBMET03719 | DBMET03719 | |
| 0.346 | 0.006 | 0.376 | Focal adhesion kinase 2 inhibitor | 0.152 0.127 DBMET03717 0.308 0.013 DBMET03709 0.373 0.005 DBMET03713 0.347 0.006 DBMET03715 0.222 0.053 DBMET03718 0.376 0.005 DBMET03710 0.31 0.013 DBMET03712 0.328 0.009 DBMET03711 0.288 0.02 DBMET03719 | DBMET03710 | |
| 0.336 | 0.005 | 0.345 | Janus tyrosine kinase 2 inhibitor | 0.163 0.017 DBMET03717 0.27 0.006 DBMET03709 0.281 0.006 DBMET03714 0.128 0.026 DBMET03713 0.124 0.027 DBMET03715 0.234 0.009 DBMET03718 0.25 0.008 DBMET03710 0.091 0.04 DBMET03712 0.089 0.042 DBMET03711 0.345 0.005 DBMET03719 | DBMET03719 | |
| 0.327 | 0.007 | 0.362 | I kappa B kinase epsilon inhibitor | 0.222 0.054 DBMET03717 0.296 0.016 DBMET03709 0.204 0.068 DBMET03714 0.362 0.004 DBMET03713 0.309 0.012 DBMET03715 0.294 0.017 DBMET03718 0.331 0.007 DBMET03710 0.274 0.025 DBMET03712 0.328 0.007 DBMET03711 0.354 0.005 DBMET03719 | DBMET03713 | |
| 0.35 | 0.036 | 0.395 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.239 0.117 DBMET03717 0.312 0.056 DBMET03709 0.368 0.03 DBMET03713 0.372 0.028 DBMET03715 0.319 0.051 DBMET03718 0.395 0.022 DBMET03710 0.333 0.044 DBMET03712 0.325 0.048 DBMET03711 0.362 0.032 DBMET03719 | DBMET03710 | |
| 0.321 | 0.008 | 0.362 | Polo-like kinase-3 inhibitor | 0.284 0.015 DBMET03717 0.293 0.013 DBMET03709 0.171 0.064 DBMET03714 0.288 0.014 DBMET03713 0.277 0.016 DBMET03715 0.327 0.007 DBMET03718 0.317 0.008 DBMET03710 0.242 0.027 DBMET03712 0.247 0.025 DBMET03711 0.362 0.005 DBMET03719 | DBMET03719 | |
| 0.314 | 0.01 | 0.314 | Activin receptor-like kinase 2 inhibitor | 0.21 0.032 DBMET03709 0.12 0.096 DBMET03714 0.231 0.025 DBMET03713 0.203 0.035 DBMET03715 0.119 0.098 DBMET03718 0.305 0.012 DBMET03710 0.127 0.088 DBMET03712 0.147 0.069 DBMET03711 0.259 0.019 DBMET03719 | ||
| 0.306 | 0.005 | 0.326 | Janus tyrosine kinase 3 inhibitor | 0.154 0.018 DBMET03717 0.272 0.006 DBMET03709 0.196 0.012 DBMET03714 0.119 0.026 DBMET03713 0.113 0.028 DBMET03715 0.222 0.009 DBMET03718 0.207 0.01 DBMET03710 0.097 0.034 DBMET03712 0.097 0.034 DBMET03711 0.326 0.005 DBMET03719 | DBMET03719 | |
| 0.321 | 0.02 | 0.356 | MAP-kinase-activated kinase 5 inhibitor | 0.303 0.028 DBMET03709 0.33 0.016 DBMET03713 0.323 0.019 DBMET03715 0.188 0.12 DBMET03718 0.356 0.01 DBMET03710 0.306 0.027 DBMET03712 0.312 0.024 DBMET03711 0.271 0.046 DBMET03719 | DBMET03710 | |
| 0.317 | 0.023 | 0.401 | Src kinase inhibitor | 0.214 0.048 DBMET03717 0.245 0.037 DBMET03709 0.322 0.022 DBMET03713 0.342 0.019 DBMET03715 0.304 0.025 DBMET03718 0.343 0.019 DBMET03710 0.268 0.032 DBMET03712 0.236 0.04 DBMET03711 0.401 0.012 DBMET03719 | DBMET03719 | |
| 0.302 | 0.015 | 0.383 | Glycogen synthase kinase-3 inhibitor | 0.17 0.039 DBMET03717 0.237 0.024 DBMET03709 0.274 0.018 DBMET03713 0.244 0.023 DBMET03715 0.292 0.016 DBMET03718 0.262 0.02 DBMET03710 0.186 0.035 DBMET03712 0.205 0.03 DBMET03711 0.383 0.009 DBMET03719 | DBMET03719 | |
| 0.3 | 0.014 | 0.366 | Glycogen synthase kinase-3 beta inhibitor | 0.173 0.035 DBMET03717 0.242 0.021 DBMET03709 0.27 0.017 DBMET03713 0.236 0.022 DBMET03715 0.281 0.015 DBMET03718 0.259 0.018 DBMET03710 0.181 0.033 DBMET03712 0.204 0.028 DBMET03711 0.366 0.009 DBMET03719 | DBMET03719 | |
| 0.299 | 0.018 | 0.329 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.141 0.067 DBMET03717 0.229 0.034 DBMET03709 0.329 0.013 DBMET03713 0.309 0.016 DBMET03715 0.265 0.025 DBMET03718 0.321 0.014 DBMET03710 0.243 0.03 DBMET03712 0.25 0.029 DBMET03711 0.3 0.018 DBMET03719 | DBMET03713 | |
| 0.296 | 0.019 | 0.36 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.177 0.053 DBMET03717 0.242 0.034 DBMET03709 0.312 0.016 DBMET03713 0.324 0.014 DBMET03715 0.313 0.016 DBMET03718 0.35 0.01 DBMET03710 0.276 0.024 DBMET03712 0.254 0.03 DBMET03711 0.36 0.009 DBMET03719 | DBMET03719 | |
| 0.301 | 0.025 | 0.335 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.212 0.133 DBMET03717 0.282 0.035 DBMET03709 0.294 0.028 DBMET03713 0.3 0.025 DBMET03715 0.224 0.107 DBMET03718 0.335 0.014 DBMET03710 0.281 0.035 DBMET03712 0.275 0.04 DBMET03711 0.261 0.053 DBMET03719 | DBMET03710 | |
| 0.28 | 0.011 | 0.283 | Cyclin-dependent kinase 3 inhibitor | 0.243 0.018 DBMET03717 0.259 0.014 DBMET03709 0.277 0.011 DBMET03713 0.265 0.013 DBMET03715 0.283 0.011 DBMET03718 0.255 0.015 DBMET03710 0.245 0.017 DBMET03712 0.254 0.015 DBMET03711 0.278 0.011 DBMET03719 | DBMET03718 | |
| 0.276 | 0.008 | 0.373 | MAP kinase 8 inhibitor | 0.152 0.029 DBMET03717 0.209 0.015 DBMET03709 0.246 0.01 DBMET03713 0.234 0.012 DBMET03715 0.231 0.012 DBMET03718 0.302 0.006 DBMET03710 0.176 0.021 DBMET03712 0.176 0.021 DBMET03711 0.373 0.005 DBMET03719 | DBMET03719 | |
| 0.268 | 0.006 | 0.317 | Protein kinase C mu inhibitor | 0.248 0.008 DBMET03717 0.219 0.01 DBMET03709 0.317 0.005 DBMET03714 0.112 0.047 DBMET03713 0.143 0.029 DBMET03715 0.246 0.008 DBMET03718 0.156 0.023 DBMET03710 0.112 0.047 DBMET03712 0.083 0.076 DBMET03711 0.275 0.006 DBMET03719 | DBMET03714 | |
| 0.262 | 0.004 | 0.298 | Polo-like kinase-1 inhibitor | 0.186 0.009 DBMET03717 0.213 0.005 DBMET03709 0.117 0.032 DBMET03714 0.161 0.013 DBMET03713 0.199 0.007 DBMET03715 0.27 0.004 DBMET03718 0.211 0.005 DBMET03710 0.164 0.013 DBMET03712 0.131 0.025 DBMET03711 0.298 0.004 DBMET03719 | DBMET03719 | |
| 0.285 | 0.036 | 0.531 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.134 0.11 DBMET03717 0.379 0.014 DBMET03709 0.294 0.033 DBMET03713 0.274 0.04 DBMET03715 0.278 0.038 DBMET03718 0.531 0.005 DBMET03710 0.369 0.015 DBMET03712 0.389 0.012 DBMET03711 0.283 0.037 DBMET03719 | DBMET03710 | |
| 0.253 | 0.006 | 0.253 | MAP kinase 10 inhibitor | 0.108 0.03 DBMET03717 0.202 0.009 DBMET03709 0.16 0.014 DBMET03713 0.157 0.015 DBMET03715 0.161 0.014 DBMET03718 0.225 0.008 DBMET03710 0.125 0.022 DBMET03712 0.122 0.023 DBMET03711 0.246 0.006 DBMET03719 | ||
| 0.279 | 0.039 | 0.327 | ErbB-1 antagonist | 0.177 0.121 DBMET03717 0.242 0.056 DBMET03709 0.254 0.049 DBMET03714 0.231 0.063 DBMET03713 0.202 0.086 DBMET03715 0.206 0.083 DBMET03718 0.201 0.088 DBMET03710 0.176 0.122 DBMET03712 0.198 0.091 DBMET03711 0.327 0.027 DBMET03719 | DBMET03719 | |
| 0.246 | 0.006 | 0.326 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.208 0.015 DBMET03717 0.234 0.008 DBMET03709 0.307 0.004 DBMET03713 0.246 0.006 DBMET03715 0.206 0.016 DBMET03718 0.326 0.004 DBMET03710 0.235 0.008 DBMET03712 0.283 0.004 DBMET03711 0.234 0.008 DBMET03719 | DBMET03710 | |
| 0.279 | 0.044 | 0.374 | Death-associated protein kinase 3 inhibitor | 0.193 0.079 DBMET03717 0.207 0.071 DBMET03709 0.336 0.029 DBMET03713 0.299 0.038 DBMET03715 0.232 0.059 DBMET03718 0.347 0.026 DBMET03710 0.225 0.062 DBMET03712 0.251 0.052 DBMET03711 0.374 0.021 DBMET03719 | DBMET03719 | |
| 0.241 | 0.005 | 0.386 | Syk tyrosine kinase inhibitor | 0.082 0.039 DBMET03717 0.183 0.01 DBMET03709 0.386 0.004 DBMET03713 0.231 0.006 DBMET03715 0.185 0.009 DBMET03718 0.368 0.004 DBMET03710 0.175 0.01 DBMET03712 0.293 0.004 DBMET03711 0.172 0.011 DBMET03719 | DBMET03713 | |
| 0.241 | 0.011 | 0.262 | Aurora-C kinase inhibitor | 0.205 0.018 DBMET03717 0.206 0.018 DBMET03709 0.215 0.016 DBMET03713 0.186 0.024 DBMET03715 0.262 0.008 DBMET03718 0.19 0.023 DBMET03710 0.161 0.039 DBMET03712 0.178 0.028 DBMET03711 0.249 0.01 DBMET03719 | DBMET03718 | |
| 0.226 | 0.006 | 0.226 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | 0.089 0.058 DBMET03717 0.223 0.007 DBMET03709 0.101 0.044 DBMET03714 0.101 0.044 DBMET03713 0.167 0.016 DBMET03715 0.208 0.009 DBMET03718 0.217 0.007 DBMET03710 0.165 0.017 DBMET03712 0.1 0.045 DBMET03711 0.174 0.014 DBMET03719 | ||
| 0.266 | 0.049 | 0.399 | Clk dual-specificity kinase inhibitor | 0.167 0.1 DBMET03717 0.207 0.075 DBMET03709 0.249 0.055 DBMET03713 0.197 0.081 DBMET03715 0.318 0.035 DBMET03718 0.279 0.044 DBMET03710 0.147 0.117 DBMET03712 0.182 0.09 DBMET03711 0.399 0.019 DBMET03719 | DBMET03719 | |
| 0.236 | 0.023 | 0.297 | Cyclin-dependent kinase 7 inhibitor | 0.163 0.051 DBMET03717 0.18 0.042 DBMET03709 0.227 0.025 DBMET03713 0.235 0.024 DBMET03715 0.214 0.029 DBMET03718 0.255 0.02 DBMET03710 0.18 0.042 DBMET03712 0.165 0.05 DBMET03711 0.297 0.013 DBMET03719 | DBMET03719 | |
| 0.227 | 0.016 | 0.32 | CDK/cyclin complex inhibitor | 0.149 0.03 DBMET03717 0.165 0.026 DBMET03709 0.262 0.013 DBMET03713 0.209 0.018 DBMET03715 0.275 0.011 DBMET03718 0.263 0.012 DBMET03710 0.154 0.028 DBMET03712 0.178 0.023 DBMET03711 0.32 0.009 DBMET03719 | DBMET03719 | |
| 0.219 | 0.008 | 0.226 | Bcr-Abl kinase inhibitor | 0.116 0.029 DBMET03717 0.12 0.026 DBMET03709 0.226 0.008 DBMET03713 0.191 0.011 DBMET03715 0.213 0.009 DBMET03718 0.181 0.012 DBMET03710 0.109 0.034 DBMET03712 0.124 0.024 DBMET03711 0.212 0.009 DBMET03719 | DBMET03713 | |
| 0.215 | 0.005 | 0.251 | MAP kinase kinase 10 inhibitor | 0.132 0.013 DBMET03717 0.151 0.009 DBMET03709 0.171 0.008 DBMET03713 0.175 0.007 DBMET03715 0.184 0.007 DBMET03718 0.136 0.012 DBMET03710 0.133 0.012 DBMET03712 0.123 0.014 DBMET03711 0.251 0.005 DBMET03719 | DBMET03719 | |
| 0.239 | 0.029 | 0.355 | Cyclin-dependent kinase inhibitor | 0.163 0.05 DBMET03717 0.165 0.049 DBMET03709 0.278 0.023 DBMET03713 0.229 0.031 DBMET03715 0.296 0.02 DBMET03718 0.286 0.022 DBMET03710 0.159 0.052 DBMET03712 0.181 0.043 DBMET03711 0.355 0.015 DBMET03719 | DBMET03719 | |
| 0.224 | 0.019 | 0.257 | Ephrin antagonist | 0.085 0.078 DBMET03717 0.198 0.025 DBMET03709 0.232 0.017 DBMET03713 0.206 0.023 DBMET03715 0.127 0.046 DBMET03718 0.257 0.014 DBMET03710 0.181 0.029 DBMET03712 0.197 0.025 DBMET03711 0.18 0.03 DBMET03719 | DBMET03710 | |
| 0.211 | 0.012 | 0.308 | CDK2/cyclin A inhibitor | 0.173 0.019 DBMET03717 0.173 0.019 DBMET03709 0.212 0.012 DBMET03713 0.206 0.013 DBMET03715 0.219 0.012 DBMET03718 0.244 0.01 DBMET03710 0.171 0.02 DBMET03712 0.168 0.021 DBMET03711 0.308 0.007 DBMET03719 | DBMET03719 | |
| 0.215 | 0.018 | 0.298 | MAP kinase 3 inhibitor | 0.144 0.077 DBMET03717 0.2 0.023 DBMET03709 0.264 0.006 DBMET03713 0.236 0.011 DBMET03715 0.204 0.022 DBMET03718 0.298 0.004 DBMET03710 0.223 0.015 DBMET03712 0.251 0.008 DBMET03711 0.197 0.025 DBMET03719 | DBMET03710 | |
| 0.244 | 0.048 | 0.38 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.191 0.084 DBMET03717 0.204 0.074 DBMET03709 0.242 0.049 DBMET03714 0.219 0.063 DBMET03713 0.176 0.096 DBMET03715 0.359 0.016 DBMET03718 0.238 0.051 DBMET03710 0.173 0.099 DBMET03711 0.38 0.013 DBMET03719 | DBMET03719 | |
| 0.211 | 0.016 | 0.242 | CF transmembrane conductance regulator agonist | 0.138 0.1 DBMET03717 0.158 0.063 DBMET03709 0.185 0.032 DBMET03714 0.207 0.018 DBMET03713 0.201 0.021 DBMET03715 0.164 0.054 DBMET03718 0.242 0.008 DBMET03710 0.149 0.078 DBMET03712 0.155 0.068 DBMET03711 0.194 0.025 DBMET03719 | DBMET03710 | |
| 0.217 | 0.023 | 0.347 | MAP kinase kinase inhibitor | 0.104 0.091 DBMET03717 0.153 0.05 DBMET03709 0.136 0.06 DBMET03714 0.228 0.02 DBMET03713 0.194 0.03 DBMET03715 0.347 0.005 DBMET03718 0.267 0.013 DBMET03710 0.132 0.063 DBMET03712 0.166 0.043 DBMET03711 0.295 0.009 DBMET03719 | DBMET03718 | |
| 0.206 | 0.013 | 0.264 | Protein kinase C gamma inhibitor | 0.137 0.04 DBMET03717 0.157 0.027 DBMET03709 0.156 0.028 DBMET03714 0.264 0.005 DBMET03713 0.144 0.035 DBMET03715 0.169 0.023 DBMET03718 0.207 0.013 DBMET03710 0.104 0.07 DBMET03712 0.221 0.01 DBMET03711 0.204 0.013 DBMET03719 | DBMET03713 | |
| 0.196 | 0.005 | 0.303 | MAP kinase kinase 9 inhibitor | 0.071 0.02 DBMET03717 0.085 0.013 DBMET03709 0.067 0.024 DBMET03713 0.082 0.015 DBMET03715 0.303 0.003 DBMET03718 0.081 0.015 DBMET03710 0.053 0.044 DBMET03712 0.266 0.004 DBMET03719 | DBMET03718 | |
| 0.195 | 0.007 | 0.331 | CDK9/cyclin T1 inhibitor | 0.126 0.013 DBMET03717 0.136 0.012 DBMET03709 0.265 0.005 DBMET03713 0.187 0.007 DBMET03715 0.216 0.006 DBMET03718 0.243 0.005 DBMET03710 0.132 0.012 DBMET03712 0.162 0.009 DBMET03711 0.331 0.005 DBMET03719 | DBMET03719 | |
| 0.287 | 0.1 | 0.399 | Angiogenesis inhibitor | 0.263 0.114 DBMET03717 0.248 0.125 DBMET03709 0.36 0.067 DBMET03713 0.399 0.054 DBMET03715 0.336 0.077 DBMET03718 0.395 0.055 DBMET03710 0.353 0.07 DBMET03712 0.305 0.09 DBMET03711 0.333 0.078 DBMET03719 | DBMET03715 | |
| 0.222 | 0.038 | 0.297 | Protein-tyrosine kinase Lyn inhibitor | 0.126 0.081 DBMET03717 0.172 0.056 DBMET03709 0.231 0.035 DBMET03713 0.228 0.036 DBMET03715 0.216 0.04 DBMET03718 0.297 0.019 DBMET03710 0.18 0.053 DBMET03712 0.172 0.056 DBMET03711 0.28 0.023 DBMET03719 | DBMET03710 | |
| 0.191 | 0.008 | 0.302 | Transcription factor STAT6 inhibitor | 0.125 0.052 DBMET03709 0.134 0.038 DBMET03714 0.259 0.004 DBMET03713 0.302 0.004 DBMET03715 0.28 0.004 DBMET03710 0.165 0.015 DBMET03712 0.151 0.023 DBMET03711 0.114 0.071 DBMET03719 | DBMET03715 | |
| 0.197 | 0.014 | 0.197 | Activin receptor-like kinase 4 inhibitor | 0.125 0.046 DBMET03717 0.155 0.026 DBMET03709 0.097 0.092 DBMET03714 0.122 0.05 DBMET03713 0.134 0.038 DBMET03715 0.151 0.028 DBMET03718 0.15 0.029 DBMET03710 0.11 0.066 DBMET03712 0.097 0.093 DBMET03711 0.186 0.017 DBMET03719 | ||
| 0.194 | 0.012 | 0.205 | Insulin growth factor antagonist | 0.118 0.035 DBMET03709 0.205 0.01 DBMET03713 0.177 0.015 DBMET03715 0.123 0.032 DBMET03718 0.204 0.01 DBMET03710 0.104 0.044 DBMET03712 0.123 0.032 DBMET03711 0.138 0.026 DBMET03719 | DBMET03713 | |
| 0.198 | 0.016 | 0.198 | MAP3K9 inhibitor | 0.164 0.041 DBMET03717 0.188 0.021 DBMET03709 0.163 0.043 DBMET03714 0.18 0.026 DBMET03713 0.15 0.06 DBMET03715 0.189 0.021 DBMET03718 0.169 0.036 DBMET03710 0.138 0.079 DBMET03712 0.17 0.036 DBMET03711 0.185 0.023 DBMET03719 | ||
| 0.222 | 0.041 | 0.247 | Growth factor antagonist | 0.114 0.098 DBMET03717 0.162 0.062 DBMET03709 0.203 0.045 DBMET03713 0.188 0.05 DBMET03715 0.194 0.048 DBMET03718 0.223 0.04 DBMET03710 0.143 0.074 DBMET03712 0.144 0.073 DBMET03711 0.247 0.036 DBMET03719 | DBMET03719 | |
| 0.242 | 0.061 | 0.309 | EphB2 antagonist | 0.192 0.094 DBMET03709 0.288 0.039 DBMET03713 0.265 0.049 DBMET03715 0.141 0.139 DBMET03718 0.309 0.033 DBMET03710 0.218 0.076 DBMET03712 0.233 0.067 DBMET03711 0.193 0.093 DBMET03719 | DBMET03710 | |
| 0.183 | 0.004 | 0.69 | Cathepsin K inhibitor | 0.131 0.004 DBMET03717 0.14 0.004 DBMET03709 0.69 0.002 DBMET03714 0.158 0.004 DBMET03718 0.219 0.004 DBMET03719 | DBMET03714 | |
| 0.216 | 0.037 | 0.333 | Glycogen synthase kinase-3 alpha inhibitor | 0.15 0.067 DBMET03709 0.333 0.012 DBMET03713 0.229 0.033 DBMET03715 0.247 0.027 DBMET03718 0.291 0.018 DBMET03710 0.159 0.06 DBMET03712 0.258 0.024 DBMET03711 0.263 0.024 DBMET03719 | DBMET03713 | |
| 0.21 | 0.031 | 0.282 | CDC-like kinase 1 inhibitor | 0.163 0.06 DBMET03717 0.184 0.045 DBMET03709 0.114 0.101 DBMET03714 0.195 0.039 DBMET03713 0.138 0.079 DBMET03715 0.221 0.026 DBMET03718 0.195 0.039 DBMET03710 0.111 0.106 DBMET03712 0.164 0.059 DBMET03711 0.282 0.012 DBMET03719 | DBMET03719 | |
| 0.189 | 0.011 | 0.199 | Insulin like growth factor 1 antagonist | 0.111 0.034 DBMET03709 0.18 0.013 DBMET03713 0.172 0.015 DBMET03715 0.114 0.032 DBMET03718 0.199 0.01 DBMET03710 0.1 0.042 DBMET03712 0.103 0.04 DBMET03711 0.129 0.026 DBMET03719 | DBMET03710 | |
| 0.189 | 0.013 | 0.189 | ALK inhibitor | 0.077 0.064 DBMET03717 0.133 0.024 DBMET03709 0.151 0.019 DBMET03713 0.152 0.019 DBMET03715 0.13 0.025 DBMET03718 0.164 0.017 DBMET03710 0.108 0.036 DBMET03712 0.099 0.042 DBMET03711 0.154 0.019 DBMET03719 | ||
| 0.229 | 0.057 | 0.346 | MAP kinase kinase 3 inhibitor | 0.216 0.083 DBMET03717 0.212 0.09 DBMET03709 0.346 0.004 DBMET03714 0.21 0.096 DBMET03715 0.225 0.065 DBMET03718 0.244 0.038 DBMET03710 0.193 0.144 DBMET03712 0.288 0.01 DBMET03719 | DBMET03714 | |
| 0.225 | 0.054 | 0.292 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.167 0.11 DBMET03717 0.199 0.074 DBMET03709 0.255 0.042 DBMET03713 0.234 0.05 DBMET03715 0.25 0.043 DBMET03718 0.292 0.031 DBMET03710 0.206 0.068 DBMET03712 0.213 0.062 DBMET03711 0.272 0.036 DBMET03719 | DBMET03710 | |
| 0.209 | 0.038 | 0.302 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.149 0.075 DBMET03717 0.158 0.067 DBMET03709 0.236 0.029 DBMET03713 0.189 0.048 DBMET03715 0.198 0.043 DBMET03718 0.228 0.031 DBMET03710 0.142 0.081 DBMET03712 0.173 0.057 DBMET03711 0.302 0.015 DBMET03719 | DBMET03719 | |
| 0.187 | 0.017 | 0.276 | Insulin receptor antagonist | 0.135 0.034 DBMET03709 0.171 0.021 DBMET03713 0.237 0.009 DBMET03715 0.153 0.026 DBMET03718 0.276 0.005 DBMET03710 0.187 0.017 DBMET03712 0.121 0.041 DBMET03711 0.163 0.024 DBMET03719 | DBMET03710 | |
| 0.196 | 0.027 | 0.265 | Cyclin-dependent kinase 1 inhibitor | 0.131 0.049 DBMET03717 0.137 0.046 DBMET03709 0.23 0.021 DBMET03713 0.178 0.031 DBMET03715 0.253 0.017 DBMET03718 0.214 0.024 DBMET03710 0.126 0.052 DBMET03712 0.152 0.04 DBMET03711 0.265 0.015 DBMET03719 | DBMET03719 | |
| 0.194 | 0.025 | 0.302 | Cyclin-dependent kinase 2 inhibitor | 0.133 0.045 DBMET03717 0.141 0.042 DBMET03709 0.202 0.024 DBMET03713 0.182 0.028 DBMET03715 0.236 0.019 DBMET03718 0.237 0.018 DBMET03710 0.132 0.046 DBMET03712 0.141 0.042 DBMET03711 0.302 0.012 DBMET03719 | DBMET03719 | |
| 0.242 | 0.076 | 0.405 | Dyrk kinase inhibitor | 0.168 0.12 DBMET03717 0.184 0.108 DBMET03709 0.31 0.049 DBMET03713 0.172 0.116 DBMET03715 0.333 0.041 DBMET03718 0.275 0.061 DBMET03710 0.235 0.079 DBMET03711 0.405 0.025 DBMET03719 | DBMET03719 | |
| 0.2 | 0.036 | 0.377 | Cytokine production inhibitor | 0.207 0.034 DBMET03709 0.361 0.009 DBMET03713 0.335 0.011 DBMET03715 0.186 0.041 DBMET03718 0.377 0.008 DBMET03710 0.342 0.01 DBMET03712 0.366 0.009 DBMET03711 0.171 0.048 DBMET03719 | DBMET03710 | |
| 0.175 | 0.013 | 0.231 | Leucine-rich repeat kinase 2 inhibitor | 0.167 0.015 DBMET03709 0.119 0.032 DBMET03713 0.116 0.034 DBMET03715 0.231 0.007 DBMET03710 0.11 0.037 DBMET03712 0.113 0.035 DBMET03711 0.077 0.061 DBMET03719 | DBMET03710 | |
| 0.197 | 0.036 | 0.265 | c-Src kinase inhibitor | 0.125 0.071 DBMET03717 0.153 0.053 DBMET03709 0.225 0.029 DBMET03713 0.265 0.023 DBMET03715 0.198 0.036 DBMET03718 0.213 0.032 DBMET03710 0.2 0.035 DBMET03712 0.163 0.049 DBMET03711 0.256 0.024 DBMET03719 | DBMET03715 | |
| 0.217 | 0.058 | 0.333 | CDC-like kinase 2 inhibitor | 0.138 0.103 DBMET03717 0.144 0.097 DBMET03709 0.255 0.044 DBMET03713 0.213 0.06 DBMET03715 0.297 0.032 DBMET03718 0.265 0.041 DBMET03710 0.142 0.099 DBMET03712 0.17 0.082 DBMET03711 0.333 0.024 DBMET03719 | DBMET03719 | |
| 0.23 | 0.071 | 0.311 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.179 0.109 DBMET03709 0.243 0.064 DBMET03714 0.23 0.071 DBMET03713 0.263 0.054 DBMET03715 0.171 0.118 DBMET03718 0.311 0.035 DBMET03710 0.21 0.083 DBMET03712 0.174 0.114 DBMET03711 0.278 0.048 DBMET03719 | DBMET03710 | |
| 0.19 | 0.034 | 0.219 | Aurora-B kinase inhibitor | 0.102 0.08 DBMET03709 0.161 0.042 DBMET03713 0.217 0.027 DBMET03715 0.195 0.032 DBMET03718 0.219 0.026 DBMET03710 0.117 0.067 DBMET03712 0.216 0.027 DBMET03719 | DBMET03710 | |
| 0.168 | 0.013 | 0.189 | CDK1/cyclin B1 inhibitor | 0.107 0.026 DBMET03717 0.121 0.022 DBMET03709 0.189 0.009 DBMET03713 0.177 0.011 DBMET03715 0.177 0.011 DBMET03718 0.175 0.012 DBMET03710 0.133 0.019 DBMET03712 0.139 0.018 DBMET03711 0.189 0.009 DBMET03719 | DBMET03719 | |
| 0.184 | 0.029 | 0.236 | Aurora-A kinase inhibitor | 0.091 0.074 DBMET03717 0.124 0.052 DBMET03709 0.236 0.019 DBMET03713 0.207 0.024 DBMET03715 0.171 0.033 DBMET03718 0.215 0.023 DBMET03710 0.142 0.043 DBMET03712 0.15 0.039 DBMET03711 0.205 0.024 DBMET03719 | DBMET03713 | |
| 0.173 | 0.029 | 0.256 | Granulocyte macrophage colony stimulating factor antagonist | 0.094 0.079 DBMET03709 0.112 0.06 DBMET03713 0.143 0.039 DBMET03715 0.103 0.068 DBMET03718 0.256 0.013 DBMET03710 0.157 0.034 DBMET03719 | DBMET03710 | |
| 0.238 | 0.096 | 0.364 | Transcription factor STAT inhibitor | 0.234 0.099 DBMET03714 0.364 0.029 DBMET03713 0.324 0.044 DBMET03715 0.293 0.06 DBMET03710 0.185 0.16 DBMET03712 0.216 0.116 DBMET03711 | DBMET03713 | |
| 0.186 | 0.046 | 0.234 | Tyrosine-protein kinase receptor antagonist | 0.114 0.093 DBMET03709 0.165 0.057 DBMET03718 0.143 0.068 DBMET03710 0.234 0.03 DBMET03719 | DBMET03719 | |
| 0.146 | 0.007 | 0.731 | Cathepsin B inhibitor | 0.129 0.009 DBMET03717 0.12 0.011 DBMET03709 0.731 0.003 DBMET03714 0.133 0.009 DBMET03718 0.179 0.005 DBMET03719 | DBMET03714 | |
| 0.202 | 0.063 | 0.353 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.139 0.097 DBMET03709 0.232 0.051 DBMET03713 0.248 0.046 DBMET03715 0.229 0.052 DBMET03718 0.353 0.026 DBMET03710 0.185 0.071 DBMET03712 0.16 0.082 DBMET03711 0.278 0.038 DBMET03719 | DBMET03710 | |
| 0.18 | 0.042 | 0.18 | Tyrosine-protein kinase receptor FLT3 inhibitor | 0.096 0.082 DBMET03709 0.159 0.049 DBMET03713 0.131 0.062 DBMET03715 0.098 0.081 DBMET03718 0.176 0.044 DBMET03710 0.153 0.052 DBMET03719 | ||
| 0.188 | 0.052 | 0.319 | Protein kinase C nu inhibitor | 0.177 0.057 DBMET03717 0.14 0.076 DBMET03709 0.246 0.035 DBMET03713 0.21 0.044 DBMET03715 0.253 0.034 DBMET03718 0.31 0.022 DBMET03710 0.16 0.064 DBMET03712 0.177 0.057 DBMET03711 0.319 0.021 DBMET03719 | DBMET03719 | |
| 0.145 | 0.01 | 0.185 | MAP kinase kinase 8 inhibitor | 0.093 0.026 DBMET03717 0.11 0.018 DBMET03709 0.153 0.009 DBMET03713 0.147 0.01 DBMET03715 0.124 0.014 DBMET03718 0.185 0.007 DBMET03710 0.112 0.017 DBMET03712 0.111 0.018 DBMET03711 0.138 0.011 DBMET03719 | DBMET03710 | |
| 0.146 | 0.01 | 0.146 | Focal adhesion kinase 1 inhibitor | 0.092 0.036 DBMET03717 0.127 0.015 DBMET03709 0.136 0.013 DBMET03713 0.132 0.014 DBMET03715 0.107 0.025 DBMET03718 0.136 0.013 DBMET03710 0.117 0.019 DBMET03712 0.117 0.02 DBMET03711 0.125 0.016 DBMET03719 | ||
| 0.182 | 0.049 | 0.326 | Protein kinase (CK1) gamma 1 inhibitor | 0.142 0.076 DBMET03717 0.14 0.077 DBMET03709 0.22 0.036 DBMET03713 0.212 0.038 DBMET03715 0.215 0.037 DBMET03718 0.286 0.022 DBMET03710 0.16 0.061 DBMET03712 0.158 0.063 DBMET03711 0.326 0.016 DBMET03719 | DBMET03719 | |
| 0.245 | 0.112 | 0.245 | Nootropic | 0.227 0.128 DBMET03709 0.184 0.182 DBMET03713 0.199 0.159 DBMET03715 0.194 0.167 DBMET03718 0.198 0.16 DBMET03710 0.187 0.176 DBMET03712 0.227 0.128 DBMET03719 | ||
| 0.179 | 0.047 | 0.227 | Ribosomal protein S6 kinase inhibitor | 0.121 0.089 DBMET03709 0.121 0.089 DBMET03713 0.147 0.067 DBMET03715 0.167 0.054 DBMET03718 0.152 0.063 DBMET03710 0.227 0.027 DBMET03719 | DBMET03719 | |
| 0.187 | 0.056 | 0.336 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.12 0.101 DBMET03717 0.15 0.078 DBMET03709 0.253 0.036 DBMET03713 0.214 0.046 DBMET03715 0.279 0.03 DBMET03718 0.336 0.018 DBMET03710 0.172 0.064 DBMET03712 0.193 0.053 DBMET03711 0.318 0.022 DBMET03719 | DBMET03710 | |
| 0.145 | 0.014 | 0.152 | Tyk2 inhibitor | 0.116 0.022 DBMET03709 0.129 0.018 DBMET03714 0.116 0.022 DBMET03718 0.093 0.03 DBMET03710 0.152 0.013 DBMET03719 | DBMET03719 | |
| 0.18 | 0.052 | 0.315 | Protein kinase (CK1) gamma inhibitor | 0.139 0.074 DBMET03717 0.129 0.082 DBMET03709 0.215 0.039 DBMET03713 0.184 0.05 DBMET03715 0.235 0.034 DBMET03718 0.258 0.028 DBMET03710 0.133 0.079 DBMET03712 0.148 0.068 DBMET03711 0.315 0.015 DBMET03719 | DBMET03719 | |
| 0.173 | 0.046 | 0.236 | Vascular endothelial growth factor antagonist | 0.107 0.077 DBMET03717 0.119 0.069 DBMET03709 0.161 0.05 DBMET03713 0.171 0.047 DBMET03715 0.175 0.046 DBMET03718 0.181 0.044 DBMET03710 0.119 0.069 DBMET03712 0.105 0.079 DBMET03711 0.236 0.031 DBMET03719 | DBMET03719 | |
| 0.177 | 0.054 | 0.215 | Cyclin-dependent kinase 8 inhibitor | 0.12 0.118 DBMET03709 0.142 0.088 DBMET03714 0.164 0.066 DBMET03713 0.199 0.036 DBMET03715 0.179 0.053 DBMET03718 0.215 0.027 DBMET03710 0.144 0.085 DBMET03712 0.191 0.042 DBMET03719 | DBMET03710 | |
| 0.155 | 0.033 | 0.177 | MAP kinase kinase kinase inhibitor | 0.092 0.074 DBMET03709 0.106 0.061 DBMET03714 0.102 0.064 DBMET03713 0.177 0.025 DBMET03718 0.136 0.042 DBMET03710 0.167 0.028 DBMET03719 | DBMET03718 | |
| 0.165 | 0.043 | 0.281 | Protein kinase (CK1) gamma 2 inhibitor | 0.126 0.061 DBMET03717 0.118 0.067 DBMET03709 0.193 0.034 DBMET03713 0.16 0.045 DBMET03715 0.216 0.028 DBMET03718 0.233 0.024 DBMET03710 0.115 0.069 DBMET03712 0.132 0.057 DBMET03711 0.281 0.014 DBMET03719 | DBMET03719 | |
| 0.16 | 0.039 | 0.211 | Platelet activating factor antagonist | 0.101 0.078 DBMET03717 0.107 0.073 DBMET03709 0.146 0.047 DBMET03713 0.118 0.064 DBMET03715 0.149 0.045 DBMET03718 0.111 0.07 DBMET03710 0.211 0.024 DBMET03719 | DBMET03719 | |
| 0.135 | 0.014 | 0.159 | Cyclin-dependent kinase 4 inhibitor | 0.097 0.027 DBMET03717 0.105 0.024 DBMET03709 0.159 0.011 DBMET03713 0.131 0.015 DBMET03715 0.113 0.021 DBMET03718 0.137 0.014 DBMET03710 0.101 0.026 DBMET03712 0.116 0.02 DBMET03711 0.139 0.014 DBMET03719 | DBMET03713 | |
| 0.165 | 0.044 | 0.227 | Vascular endothelial growth factor 2 antagonist | 0.107 0.067 DBMET03709 0.143 0.051 DBMET03713 0.161 0.046 DBMET03715 0.163 0.045 DBMET03718 0.166 0.044 DBMET03710 0.105 0.068 DBMET03712 0.088 0.081 DBMET03711 0.227 0.03 DBMET03719 | DBMET03719 | |
| 0.192 | 0.071 | 0.268 | Growth factor agonist | 0.152 0.136 DBMET03717 0.15 0.141 DBMET03709 0.198 0.064 DBMET03713 0.268 0.024 DBMET03715 0.196 0.067 DBMET03718 0.173 0.098 DBMET03710 0.214 0.051 DBMET03712 0.152 0.136 DBMET03711 0.2 0.063 DBMET03719 | DBMET03715 | |
| 0.161 | 0.041 | 0.175 | Epidermal growth factor receptor kinase inhibitor | 0.125 0.068 DBMET03717 0.148 0.049 DBMET03709 0.163 0.04 DBMET03713 0.145 0.052 DBMET03715 0.154 0.046 DBMET03718 0.164 0.04 DBMET03710 0.133 0.06 DBMET03712 0.146 0.051 DBMET03711 0.175 0.035 DBMET03719 | DBMET03719 | |
| 0.124 | 0.004 | 0.604 | Cathepsin S inhibitor | 0.081 0.004 DBMET03717 0.127 0.004 DBMET03709 0.604 0.002 DBMET03714 0.104 0.004 DBMET03718 0.132 0.004 DBMET03719 | DBMET03714 | |
| 0.137 | 0.017 | 0.165 | Macrophage colony-stimulating factor 1 receptor antagonist | 0.086 0.037 DBMET03709 0.078 0.043 DBMET03713 0.087 0.036 DBMET03715 0.092 0.033 DBMET03718 0.165 0.012 DBMET03710 0.122 0.022 DBMET03719 | DBMET03710 | |
| 0.234 | 0.115 | 0.361 | Hypoxia-inducible factor 1 alpha inhibitor | 0.18 0.179 DBMET03714 0.361 0.041 DBMET03713 0.249 0.101 DBMET03711 | DBMET03713 | |
| 0.124 | 0.005 | 0.182 | CDK7/cyclin H inhibitor | 0.077 0.009 DBMET03717 0.083 0.008 DBMET03709 0.182 0.004 DBMET03713 0.117 0.005 DBMET03715 0.115 0.005 DBMET03718 0.12 0.005 DBMET03710 0.08 0.008 DBMET03712 0.097 0.005 DBMET03711 0.146 0.005 DBMET03719 | DBMET03713 | |
| 0.161 | 0.044 | 0.231 | TRKA antagonist | 0.106 0.082 DBMET03709 0.158 0.046 DBMET03718 0.122 0.066 DBMET03710 0.231 0.022 DBMET03719 | DBMET03719 | |
| 0.132 | 0.016 | 0.187 | CDK1/cyclin B inhibitor | 0.089 0.029 DBMET03717 0.097 0.026 DBMET03709 0.167 0.012 DBMET03713 0.118 0.019 DBMET03715 0.187 0.01 DBMET03718 0.131 0.016 DBMET03710 0.087 0.03 DBMET03712 0.11 0.021 DBMET03711 0.187 0.01 DBMET03719 | DBMET03719 | |
| 0.129 | 0.014 | 0.24 | Janus tyrosine kinase 1 inhibitor | 0.055 0.042 DBMET03717 0.112 0.019 DBMET03709 0.24 0.004 DBMET03714 0.106 0.021 DBMET03718 0.115 0.018 DBMET03710 0.141 0.011 DBMET03719 | DBMET03714 | |
| 0.152 | 0.037 | 0.165 | Death-associated protein kinase 1 inhibitor | 0.138 0.062 DBMET03709 0.153 0.036 DBMET03713 0.165 0.023 DBMET03715 0.119 0.116 DBMET03718 0.158 0.029 DBMET03710 0.15 0.04 DBMET03712 0.139 0.06 DBMET03711 0.127 0.091 DBMET03719 | DBMET03715 | |
| 0.161 | 0.047 | 0.193 | Protein kinase (CK1) delta inhibitor | 0.124 0.07 DBMET03709 0.151 0.052 DBMET03713 0.16 0.047 DBMET03715 0.139 0.06 DBMET03718 0.193 0.031 DBMET03710 0.124 0.07 DBMET03712 0.111 0.081 DBMET03711 0.178 0.038 DBMET03719 | DBMET03710 | |
| 0.13 | 0.016 | 0.179 | CDK2/cyclin E inhibitor | 0.082 0.03 DBMET03717 0.09 0.026 DBMET03709 0.161 0.011 DBMET03713 0.129 0.016 DBMET03715 0.156 0.012 DBMET03718 0.142 0.014 DBMET03710 0.09 0.026 DBMET03712 0.105 0.021 DBMET03711 0.179 0.009 DBMET03719 | DBMET03719 | |
| 0.133 | 0.021 | 0.337 | I kappa B kinase inhibitor | 0.091 0.048 DBMET03717 0.082 0.057 DBMET03709 0.102 0.037 DBMET03714 0.09 0.048 DBMET03713 0.148 0.017 DBMET03715 0.311 0.004 DBMET03718 0.164 0.013 DBMET03710 0.091 0.047 DBMET03712 0.337 0.004 DBMET03719 | DBMET03719 | |
| 0.14 | 0.031 | 0.219 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | 0.115 0.043 DBMET03709 0.106 0.049 DBMET03713 0.098 0.055 DBMET03715 0.169 0.023 DBMET03718 0.141 0.031 DBMET03710 0.081 0.071 DBMET03712 0.084 0.068 DBMET03711 0.219 0.015 DBMET03719 | DBMET03719 | |
| 0.195 | 0.087 | 0.274 | Antimitotic | 0.151 0.12 DBMET03717 0.169 0.104 DBMET03709 0.182 0.095 DBMET03713 0.145 0.127 DBMET03715 0.219 0.074 DBMET03718 0.198 0.085 DBMET03710 0.152 0.12 DBMET03711 0.274 0.051 DBMET03719 | DBMET03719 | |
| 0.13 | 0.023 | 0.187 | Raf kinase inhibitor | 0.063 0.061 DBMET03717 0.104 0.03 DBMET03709 0.091 0.038 DBMET03713 0.081 0.044 DBMET03715 0.15 0.019 DBMET03718 0.115 0.027 DBMET03710 0.069 0.056 DBMET03712 0.073 0.052 DBMET03711 0.187 0.014 DBMET03719 | DBMET03719 | |
| 0.118 | 0.011 | 0.125 | Polo-like kinase-2 inhibitor | 0.102 0.024 DBMET03717 0.109 0.018 DBMET03709 0.108 0.018 DBMET03713 0.119 0.011 DBMET03715 0.117 0.012 DBMET03718 0.125 0.008 DBMET03710 0.11 0.017 DBMET03712 0.095 0.03 DBMET03711 0.124 0.009 DBMET03719 | DBMET03710 | |
| 0.132 | 0.026 | 0.133 | ErbB-4 antagonist | 0.098 0.041 DBMET03709 0.132 0.026 DBMET03713 0.124 0.029 DBMET03715 0.097 0.042 DBMET03718 0.133 0.026 DBMET03710 0.09 0.045 DBMET03712 0.093 0.044 DBMET03711 0.125 0.029 DBMET03719 | DBMET03710 | |
| 0.13 | 0.024 | 0.132 | ErbB-2 antagonist | 0.073 0.055 DBMET03717 0.093 0.038 DBMET03709 0.122 0.027 DBMET03713 0.109 0.032 DBMET03715 0.108 0.032 DBMET03718 0.098 0.036 DBMET03710 0.078 0.05 DBMET03712 0.082 0.046 DBMET03711 0.132 0.024 DBMET03719 | DBMET03719 | |
| 0.127 | 0.023 | 0.171 | Interleukin 12 antagonist | 0.106 0.044 DBMET03709 0.171 0.008 DBMET03713 0.152 0.012 DBMET03715 0.136 0.018 DBMET03710 0.131 0.021 DBMET03712 0.143 0.015 DBMET03711 | DBMET03713 | |
| 0.171 | 0.068 | 0.292 | Protein kinase (CK1) gamma 3 inhibitor | 0.159 0.08 DBMET03717 0.138 0.104 DBMET03709 0.204 0.045 DBMET03713 0.188 0.054 DBMET03715 0.221 0.037 DBMET03718 0.255 0.026 DBMET03710 0.155 0.084 DBMET03712 0.164 0.075 DBMET03711 0.292 0.018 DBMET03719 | DBMET03719 | |
| 0.179 | 0.079 | 0.275 | CDC-like kinase 4 inhibitor | 0.131 0.116 DBMET03709 0.214 0.061 DBMET03713 0.167 0.087 DBMET03715 0.238 0.05 DBMET03718 0.228 0.054 DBMET03710 0.154 0.098 DBMET03711 0.275 0.038 DBMET03719 | DBMET03719 | |
| 0.109 | 0.01 | 0.118 | ZAP-70 protein tyrosine kinase inhibitor | 0.091 0.021 DBMET03717 0.1 0.014 DBMET03709 0.117 0.008 DBMET03713 0.107 0.011 DBMET03715 0.097 0.016 DBMET03718 0.118 0.008 DBMET03710 0.099 0.015 DBMET03712 0.104 0.012 DBMET03711 0.105 0.012 DBMET03719 | DBMET03710 | |
| 0.11 | 0.012 | 0.132 | CDK4/cyclin D inhibitor | 0.075 0.024 DBMET03717 0.089 0.018 DBMET03709 0.132 0.009 DBMET03713 0.108 0.012 DBMET03715 0.096 0.015 DBMET03718 0.115 0.011 DBMET03710 0.087 0.019 DBMET03712 0.099 0.015 DBMET03711 0.121 0.01 DBMET03719 | DBMET03713 | |
| 0.125 | 0.027 | 0.162 | Platelet growth factor antagonist | 0.082 0.055 DBMET03717 0.104 0.038 DBMET03709 0.14 0.022 DBMET03713 0.114 0.033 DBMET03715 0.123 0.028 DBMET03718 0.115 0.032 DBMET03710 0.094 0.045 DBMET03712 0.11 0.034 DBMET03711 0.162 0.016 DBMET03719 | DBMET03719 | |
| 0.14 | 0.042 | 0.25 | Polo-like kinase-4 inhibitor | 0.18 0.021 DBMET03709 0.167 0.027 DBMET03713 0.143 0.04 DBMET03715 0.25 0.008 DBMET03710 0.181 0.021 DBMET03712 0.209 0.014 DBMET03711 0.12 0.056 DBMET03719 | DBMET03710 | |
| 0.115 | 0.017 | 0.115 | Caspase 7 inhibitor | 0.079 0.064 DBMET03717 0.093 0.037 DBMET03709 0.083 0.055 DBMET03714 0.099 0.029 DBMET03713 0.083 0.055 DBMET03711 | ||
| 0.138 | 0.042 | 0.19 | Platelet activating factor beta antagonist | 0.09 0.07 DBMET03709 0.175 0.03 DBMET03713 0.141 0.041 DBMET03715 0.115 0.053 DBMET03718 0.14 0.041 DBMET03710 0.092 0.068 DBMET03712 0.107 0.058 DBMET03711 0.19 0.027 DBMET03719 | DBMET03719 | |
| 0.111 | 0.016 | 0.207 | EphB4 antagonist | 0.078 0.024 DBMET03709 0.126 0.013 DBMET03713 0.101 0.018 DBMET03715 0.207 0.006 DBMET03710 0.073 0.028 DBMET03712 0.082 0.023 DBMET03711 0.053 0.046 DBMET03719 | DBMET03710 | |
| 0.186 | 0.092 | 0.267 | Platelet aggregation inhibitor | 0.267 0.045 DBMET03717 0.258 0.048 DBMET03713 0.218 0.069 DBMET03715 0.218 0.069 DBMET03718 0.156 0.121 DBMET03710 0.158 0.119 DBMET03712 0.181 0.096 DBMET03711 0.223 0.066 DBMET03719 | DBMET03717 | |
| 0.157 | 0.062 | 0.251 | Protein kinase (CK1) inhibitor | 0.115 0.096 DBMET03709 0.173 0.052 DBMET03713 0.17 0.053 DBMET03715 0.144 0.073 DBMET03718 0.251 0.026 DBMET03710 0.13 0.083 DBMET03712 0.127 0.086 DBMET03711 0.216 0.035 DBMET03719 | DBMET03710 | |
| 0.128 | 0.034 | 0.128 | Hedgehog signaling inhibitor | 0.095 0.073 DBMET03709 0.119 0.041 DBMET03713 0.101 0.062 DBMET03715 0.095 0.074 DBMET03718 0.102 0.061 DBMET03710 0.097 0.069 DBMET03719 | ||
| 0.105 | 0.013 | 0.129 | CDK4/cyclin D1 inhibitor | 0.073 0.029 DBMET03717 0.087 0.02 DBMET03709 0.129 0.009 DBMET03713 0.101 0.014 DBMET03715 0.093 0.017 DBMET03718 0.111 0.012 DBMET03710 0.085 0.021 DBMET03712 0.098 0.015 DBMET03711 0.107 0.013 DBMET03719 | DBMET03713 | |
| 0.183 | 0.091 | 0.29 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.146 0.133 DBMET03709 0.213 0.068 DBMET03713 0.196 0.08 DBMET03715 0.219 0.064 DBMET03718 0.29 0.039 DBMET03710 0.159 0.117 DBMET03712 0.17 0.104 DBMET03711 0.23 0.059 DBMET03719 | DBMET03710 | |
| 0.12 | 0.029 | 0.152 | ErbB-3 antagonist | 0.091 0.049 DBMET03709 0.152 0.018 DBMET03713 0.123 0.028 DBMET03715 0.073 0.07 DBMET03718 0.117 0.031 DBMET03710 0.094 0.046 DBMET03712 0.114 0.032 DBMET03711 0.082 0.059 DBMET03719 | DBMET03713 | |
| 0.13 | 0.041 | 0.238 | Cyclin-dependent kinase 9 inhibitor | 0.202 0.022 DBMET03713 0.115 0.049 DBMET03715 0.161 0.031 DBMET03718 0.186 0.026 DBMET03710 0.099 0.063 DBMET03711 0.238 0.016 DBMET03719 | DBMET03719 | |
| 0.11 | 0.021 | 0.244 | Cyclin A2 inhibitor | 0.06 0.047 DBMET03709 0.12 0.019 DBMET03713 0.203 0.01 DBMET03715 0.097 0.026 DBMET03718 0.244 0.008 DBMET03710 0.106 0.022 DBMET03712 0.066 0.042 DBMET03711 0.118 0.019 DBMET03719 | DBMET03710 | |
| 0.15 | 0.062 | 0.175 | MAP kinase kinase 4 inhibitor | 0.133 0.105 DBMET03717 0.141 0.082 DBMET03709 0.17 0.033 DBMET03713 0.139 0.087 DBMET03715 0.147 0.067 DBMET03718 0.175 0.028 DBMET03710 0.13 0.113 DBMET03712 0.158 0.048 DBMET03711 0.157 0.05 DBMET03719 | DBMET03710 | |
| 0.127 | 0.04 | 0.169 | Platelet activating factor alpha antagonist | 0.095 0.063 DBMET03717 0.094 0.065 DBMET03709 0.097 0.061 DBMET03713 0.107 0.054 DBMET03715 0.15 0.03 DBMET03718 0.096 0.063 DBMET03710 0.169 0.024 DBMET03719 | DBMET03719 | |
| 0.108 | 0.021 | 0.252 | Cyclin A inhibitor | 0.058 0.046 DBMET03709 0.115 0.018 DBMET03713 0.202 0.009 DBMET03715 0.088 0.028 DBMET03718 0.252 0.007 DBMET03710 0.105 0.021 DBMET03712 0.064 0.041 DBMET03711 0.11 0.02 DBMET03719 | DBMET03710 | |
| 0.12 | 0.035 | 0.18 | MAP kinase kinase 1 inhibitor | 0.092 0.067 DBMET03709 0.148 0.017 DBMET03714 0.129 0.027 DBMET03713 0.105 0.05 DBMET03715 0.18 0.008 DBMET03718 0.153 0.015 DBMET03710 0.103 0.053 DBMET03711 0.174 0.009 DBMET03719 | DBMET03718 | |
| 0.164 | 0.078 | 0.185 | Death-associated protein kinase 2 inhibitor | 0.154 0.097 DBMET03717 0.155 0.095 DBMET03709 0.176 0.06 DBMET03714 0.149 0.109 DBMET03713 0.174 0.062 DBMET03715 0.174 0.062 DBMET03718 0.167 0.073 DBMET03710 0.164 0.077 DBMET03712 0.141 0.13 DBMET03711 0.185 0.048 DBMET03719 | DBMET03719 | |
| 0.093 | 0.011 | 0.102 | Cyclin H inhibitor | 0.078 0.021 DBMET03717 0.08 0.019 DBMET03709 0.102 0.007 DBMET03713 0.087 0.014 DBMET03715 0.087 0.014 DBMET03718 0.089 0.013 DBMET03710 0.074 0.024 DBMET03712 0.087 0.014 DBMET03711 0.094 0.01 DBMET03719 | DBMET03713 | |
| 0.149 | 0.07 | 0.223 | Thiol protease inhibitor | 0.223 0.032 DBMET03714 0.126 0.105 DBMET03715 0.134 0.09 DBMET03718 0.137 0.084 DBMET03719 | DBMET03714 | |
| 0.143 | 0.065 | 0.21 | RET inhibitor | 0.107 0.09 DBMET03709 0.151 0.061 DBMET03713 0.13 0.072 DBMET03715 0.11 0.087 DBMET03718 0.21 0.04 DBMET03710 0.106 0.091 DBMET03711 0.209 0.04 DBMET03719 | DBMET03710 | |
| 0.099 | 0.023 | 0.163 | Raf kinase B inhibitor | 0.08 0.029 DBMET03709 0.066 0.036 DBMET03713 0.058 0.043 DBMET03715 0.122 0.018 DBMET03718 0.09 0.025 DBMET03710 0.052 0.048 DBMET03711 0.163 0.012 DBMET03719 | DBMET03719 | |
| 0.133 | 0.058 | 0.18 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | 0.116 0.072 DBMET03713 0.119 0.07 DBMET03715 0.153 0.046 DBMET03718 0.124 0.065 DBMET03710 0.18 0.034 DBMET03719 | DBMET03719 | |
| 0.083 | 0.01 | 0.108 | Cyclin D3 inhibitor | 0.051 0.021 DBMET03717 0.059 0.017 DBMET03709 0.108 0.006 DBMET03713 0.084 0.01 DBMET03715 0.058 0.017 DBMET03718 0.09 0.009 DBMET03710 0.06 0.017 DBMET03712 0.073 0.012 DBMET03711 0.068 0.014 DBMET03719 | DBMET03713 | |
| 0.132 | 0.059 | 0.178 | Abl kinase inhibitor | 0.115 0.072 DBMET03713 0.119 0.07 DBMET03715 0.153 0.046 DBMET03718 0.123 0.065 DBMET03710 0.178 0.034 DBMET03719 | DBMET03719 | |
| 0.13 | 0.058 | 0.16 | MAP kinase 12 inhibitor | 0.11 0.084 DBMET03709 0.151 0.041 DBMET03713 0.127 0.061 DBMET03715 0.159 0.037 DBMET03710 0.107 0.087 DBMET03712 0.123 0.066 DBMET03711 0.16 0.036 DBMET03719 | DBMET03719 | |
| 0.11 | 0.038 | 0.121 | Epidermal growth factor antagonist | 0.085 0.059 DBMET03717 0.089 0.054 DBMET03709 0.11 0.038 DBMET03713 0.099 0.046 DBMET03715 0.102 0.043 DBMET03718 0.104 0.042 DBMET03710 0.081 0.064 DBMET03712 0.085 0.058 DBMET03711 0.121 0.032 DBMET03719 | DBMET03719 | |
| 0.117 | 0.047 | 0.132 | CDC-like kinase 3 inhibitor | 0.101 0.077 DBMET03717 0.11 0.059 DBMET03709 0.126 0.036 DBMET03713 0.109 0.06 DBMET03715 0.132 0.03 DBMET03718 0.122 0.041 DBMET03710 0.101 0.076 DBMET03712 0.118 0.046 DBMET03711 0.129 0.033 DBMET03719 | DBMET03718 | |
| 0.178 | 0.108 | 0.332 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.298 0.051 DBMET03713 0.157 0.125 DBMET03715 0.27 0.059 DBMET03718 0.252 0.067 DBMET03710 0.224 0.079 DBMET03711 0.332 0.04 DBMET03719 | DBMET03719 | |
| 0.108 | 0.039 | 0.108 | Stem cell growth factor agonist | 0.075 0.072 DBMET03709 0.095 0.05 DBMET03715 0.089 0.055 DBMET03718 0.086 0.059 DBMET03710 0.09 0.055 DBMET03719 | ||
| 0.128 | 0.059 | 0.246 | Beta amyloid protein antagonist | 0.174 0.027 DBMET03709 0.101 0.088 DBMET03714 0.199 0.017 DBMET03713 0.161 0.033 DBMET03715 0.246 0.009 DBMET03710 0.205 0.015 DBMET03712 0.24 0.009 DBMET03711 0.132 0.055 DBMET03719 | DBMET03710 | |
| 0.072 | 0.004 | 0.22 | Cathepsin F inhibitor | 0.069 0.004 DBMET03717 0.066 0.004 DBMET03709 0.22 0.001 DBMET03714 0.07 0.004 DBMET03718 0.083 0.003 DBMET03719 | DBMET03714 | |
| 0.099 | 0.032 | 0.219 | Rho-associated kinase I inhibitor | 0.074 0.053 DBMET03714 0.067 0.06 DBMET03715 0.153 0.014 DBMET03718 0.219 0.008 DBMET03719 | DBMET03719 | |
| 0.088 | 0.023 | 0.091 | MAP kinase 7 inhibitor | 0.081 0.042 DBMET03709 0.086 0.027 DBMET03713 0.087 0.026 DBMET03715 0.076 0.062 DBMET03718 0.091 0.018 DBMET03710 0.079 0.047 DBMET03712 0.078 0.05 DBMET03711 0.088 0.024 DBMET03719 | DBMET03710 | |
| 0.121 | 0.055 | 0.163 | MAP kinase 13 inhibitor | 0.097 0.087 DBMET03709 0.129 0.048 DBMET03713 0.119 0.057 DBMET03715 0.149 0.036 DBMET03710 0.096 0.089 DBMET03712 0.099 0.082 DBMET03711 0.163 0.03 DBMET03719 | DBMET03719 | |
| 0.096 | 0.038 | 0.117 | MAP kinase 14 inhibitor | 0.069 0.055 DBMET03713 0.104 0.033 DBMET03715 0.081 0.046 DBMET03718 0.087 0.043 DBMET03710 0.066 0.059 DBMET03712 0.117 0.028 DBMET03719 | DBMET03719 | |
| 0.105 | 0.051 | 0.13 | Interleukin 1 beta converting enzyme inhibitor | 0.13 0.027 DBMET03717 0.102 0.055 DBMET03714 0.093 0.067 DBMET03713 0.092 0.069 DBMET03718 0.084 0.082 DBMET03719 | DBMET03717 | |
| 0.08 | 0.025 | 0.112 | Tyrosine-protein kinase EMT inhibitor | 0.062 0.036 DBMET03709 0.073 0.029 DBMET03713 0.103 0.017 DBMET03715 0.061 0.037 DBMET03718 0.112 0.015 DBMET03710 0.081 0.025 DBMET03712 0.054 0.043 DBMET03711 0.1 0.018 DBMET03719 | DBMET03710 | |
| 0.076 | 0.025 | 0.095 | Cyclin B1 inhibitor | 0.055 0.051 DBMET03717 0.064 0.039 DBMET03709 0.095 0.013 DBMET03713 0.074 0.028 DBMET03715 0.086 0.017 DBMET03718 0.084 0.019 DBMET03710 0.062 0.042 DBMET03712 0.081 0.021 DBMET03711 0.087 0.017 DBMET03719 | DBMET03713 | |
| 0.075 | 0.026 | 0.097 | Cyclin-dependent kinase 6 inhibitor | 0.097 0.011 DBMET03713 0.059 0.042 DBMET03715 0.064 0.036 DBMET03718 0.081 0.021 DBMET03710 0.068 0.032 DBMET03711 | DBMET03713 | |
| 0.084 | 0.035 | 0.101 | MAP3K7 inhibitor | 0.084 0.035 DBMET03713 0.093 0.027 DBMET03715 0.101 0.021 DBMET03710 0.072 0.051 DBMET03712 0.088 0.031 DBMET03719 | DBMET03710 | |
| 0.075 | 0.027 | 0.204 | I kappa B kinase 2 inhibitor | 0.061 0.045 DBMET03717 0.074 0.027 DBMET03714 0.093 0.015 DBMET03715 0.145 0.005 DBMET03718 0.094 0.015 DBMET03710 0.058 0.05 DBMET03712 0.204 0.004 DBMET03719 | DBMET03719 | |
| 0.103 | 0.055 | 0.106 | mTOR complex 1 inhibitor | 0.092 0.08 DBMET03709 0.103 0.056 DBMET03713 0.096 0.073 DBMET03715 0.106 0.049 DBMET03710 0.09 0.086 DBMET03711 | DBMET03710 | |
| 0.07 | 0.023 | 0.132 | Cyclin A1 inhibitor | 0.057 0.044 DBMET03709 0.081 0.014 DBMET03713 0.097 0.009 DBMET03715 0.132 0.005 DBMET03710 0.076 0.017 DBMET03712 0.067 0.026 DBMET03711 0.069 0.024 DBMET03719 | DBMET03710 | |
| 0.069 | 0.022 | 0.1 | mTOR inhibitor | 0.075 0.02 DBMET03709 0.062 0.027 DBMET03713 0.048 0.041 DBMET03715 0.1 0.012 DBMET03710 0.052 0.036 DBMET03712 0.063 0.026 DBMET03711 | DBMET03710 | |
| 0.08 | 0.035 | 0.182 | CDC7 inhibitor | 0.115 0.017 DBMET03713 0.089 0.03 DBMET03715 0.077 0.038 DBMET03718 0.182 0.006 DBMET03710 0.06 0.058 DBMET03712 0.082 0.034 DBMET03711 0.112 0.018 DBMET03719 | DBMET03710 | |
| 0.064 | 0.022 | 0.09 | Phosphatidylinositol 3-kinase beta inhibitor | 0.061 0.024 DBMET03709 0.062 0.024 DBMET03713 0.062 0.024 DBMET03715 0.09 0.014 DBMET03710 0.058 0.026 DBMET03712 0.057 0.027 DBMET03711 | DBMET03710 | |
| 0.085 | 0.045 | 0.108 | Fibroblast growth factor 3 antagonist | 0.072 0.062 DBMET03713 0.108 0.028 DBMET03715 0.084 0.045 DBMET03718 0.1 0.032 DBMET03710 0.076 0.055 DBMET03712 0.088 0.042 DBMET03719 | DBMET03715 | |
| 0.09 | 0.049 | 0.11 | AXL receptor tyrosine kinase inhibitor | 0.1 0.039 DBMET03713 0.086 0.052 DBMET03715 0.11 0.032 DBMET03710 0.073 0.072 DBMET03711 0.091 0.047 DBMET03719 | DBMET03710 | |
| 0.049 | 0.009 | 0.049 | ATM kinase inhibitor | 0.042 0.014 DBMET03709 0.04 0.018 DBMET03715 0.045 0.012 DBMET03710 0.035 0.028 DBMET03712 | ||
| 0.072 | 0.035 | 0.112 | Raf kinase C inhibitor | 0.083 0.031 DBMET03709 0.059 0.042 DBMET03713 0.057 0.045 DBMET03718 0.112 0.021 DBMET03710 0.054 0.047 DBMET03712 0.067 0.037 DBMET03711 0.059 0.042 DBMET03719 | DBMET03710 | |
| 0.074 | 0.038 | 0.092 | Fibroblast growth factor 2 antagonist | 0.069 0.042 DBMET03713 0.073 0.039 DBMET03715 0.092 0.027 DBMET03718 0.064 0.047 DBMET03710 0.065 0.045 DBMET03719 | DBMET03718 | |
| 0.067 | 0.032 | 0.108 | Cyclin D1 inhibitor | 0.096 0.009 DBMET03713 0.078 0.019 DBMET03715 0.06 0.043 DBMET03718 0.108 0.006 DBMET03710 0.071 0.027 DBMET03711 0.075 0.023 DBMET03719 | DBMET03710 | |
| 0.054 | 0.019 | 0.063 | DNA-dependent protein kinase inhibitor | 0.036 0.033 DBMET03709 0.063 0.013 DBMET03713 0.057 0.016 DBMET03715 0.056 0.018 DBMET03710 0.04 0.029 DBMET03712 0.044 0.026 DBMET03711 | DBMET03713 | |
| 0.105 | 0.072 | 0.343 | Protein kinase (CK2) alpha inhibitor | 0.146 0.044 DBMET03717 0.107 0.071 DBMET03714 0.343 0.008 DBMET03713 0.237 0.018 DBMET03718 0.121 0.061 DBMET03710 0.19 0.027 DBMET03711 0.208 0.023 DBMET03719 | DBMET03713 | |
| 0.043 | 0.011 | 0.049 | CDK6/cyclin D3 inhibitor | 0.038 0.017 DBMET03717 0.04 0.013 DBMET03709 0.049 0.007 DBMET03713 0.041 0.013 DBMET03715 0.038 0.016 DBMET03718 0.049 0.007 DBMET03710 0.038 0.016 DBMET03712 0.045 0.009 DBMET03711 0.041 0.012 DBMET03719 | DBMET03710 | |
| 0.079 | 0.049 | 0.123 | MAP kinase 11 inhibitor | 0.08 0.048 DBMET03715 0.068 0.057 DBMET03710 0.123 0.025 DBMET03719 | DBMET03719 | |
| 0.06 | 0.03 | 0.078 | Protein kinase C epsilon inhibitor | 0.056 0.035 DBMET03714 0.053 0.038 DBMET03713 0.069 0.024 DBMET03715 0.062 0.029 DBMET03718 0.067 0.026 DBMET03710 0.054 0.037 DBMET03712 0.078 0.02 DBMET03719 | DBMET03719 | |
| 0.066 | 0.036 | 0.131 | Phosphatidylinositol kinase inhibitor | 0.09 0.024 DBMET03709 0.068 0.035 DBMET03713 0.059 0.042 DBMET03715 0.131 0.014 DBMET03710 0.082 0.027 DBMET03712 0.091 0.024 DBMET03711 | DBMET03710 | |
| 0.106 | 0.076 | 0.15 | CDK3/cyclin E inhibitor | 0.11 0.07 DBMET03717 0.119 0.056 DBMET03713 0.15 0.026 DBMET03715 0.135 0.038 DBMET03718 0.111 0.069 DBMET03710 0.138 0.036 DBMET03712 0.104 0.081 DBMET03711 0.128 0.046 DBMET03719 | DBMET03715 | |
| 0.06 | 0.031 | 0.078 | Cyclin B inhibitor | 0.05 0.047 DBMET03709 0.078 0.016 DBMET03713 0.059 0.033 DBMET03715 0.074 0.019 DBMET03718 0.067 0.024 DBMET03710 0.064 0.026 DBMET03711 0.072 0.02 DBMET03719 | DBMET03713 | |
| 0.084 | 0.056 | 0.095 | MAP-kinase-activated kinase inhibitor | 0.089 0.05 DBMET03713 0.08 0.062 DBMET03715 0.095 0.044 DBMET03710 0.09 0.049 DBMET03719 | DBMET03710 | |
| 0.06 | 0.032 | 0.078 | Cyclin B2 inhibitor | 0.05 0.048 DBMET03709 0.078 0.016 DBMET03713 0.058 0.035 DBMET03715 0.071 0.02 DBMET03718 0.067 0.024 DBMET03710 0.066 0.025 DBMET03711 0.07 0.022 DBMET03719 | DBMET03713 | |
| 0.095 | 0.068 | 0.311 | Protein kinase (CK2) inhibitor | 0.13 0.042 DBMET03717 0.311 0.005 DBMET03713 0.21 0.017 DBMET03718 0.104 0.06 DBMET03710 0.204 0.018 DBMET03711 0.197 0.019 DBMET03719 | DBMET03713 | |
| 0.058 | 0.031 | 0.083 | Phosphatidylinositol 3-kinase alpha inhibitor | 0.05 0.037 DBMET03709 0.066 0.027 DBMET03713 0.055 0.033 DBMET03715 0.083 0.021 DBMET03710 0.048 0.039 DBMET03712 0.053 0.034 DBMET03711 | DBMET03710 | |
| 0.101 | 0.075 | 0.124 | EphA2 antagonist | 0.122 0.053 DBMET03713 0.111 0.064 DBMET03715 0.124 0.05 DBMET03710 0.096 0.08 DBMET03711 | DBMET03710 | |
| 0.104 | 0.078 | 0.121 | Nav1.5 sodium channel blocker | 0.101 0.083 DBMET03709 0.103 0.08 DBMET03715 0.121 0.053 DBMET03710 0.1 0.085 DBMET03712 | DBMET03710 | |
| 0.075 | 0.052 | 0.132 | Protein kinase B gamma inhibitor | 0.132 0.021 DBMET03714 0.066 0.064 DBMET03713 0.11 0.028 DBMET03715 0.08 0.046 DBMET03718 0.108 0.029 DBMET03710 0.09 0.038 DBMET03712 0.124 0.024 DBMET03719 | DBMET03714 | |
| 0.058 | 0.035 | 0.102 | Phosphatidylinositol 3-kinase gamma inhibitor | 0.08 0.02 DBMET03709 0.055 0.038 DBMET03713 0.052 0.041 DBMET03715 0.102 0.014 DBMET03710 0.073 0.023 DBMET03712 0.076 0.021 DBMET03711 | DBMET03710 | |
| 0.205 | 0.182 | 0.229 | Ca(v)3.3 blocker | 0.229 0.135 DBMET03714 | DBMET03714 | |
| 0.034 | 0.013 | 0.051 | CDK4/cyclin D3 inhibitor | 0.032 0.015 DBMET03713 0.051 0.007 DBMET03715 0.032 0.016 DBMET03710 0.046 0.008 DBMET03719 | DBMET03715 | |
| 0.092 | 0.071 | 0.137 | Vascular endothelial growth factor 1 antagonist | 0.116 0.057 DBMET03713 0.09 0.073 DBMET03715 0.122 0.053 DBMET03710 0.137 0.046 DBMET03719 | DBMET03719 | |
| 0.059 | 0.039 | 0.092 | Cathepsin L inhibitor | 0.092 0.022 DBMET03714 | DBMET03714 | |
| 0.088 | 0.069 | 0.136 | Protein kinase C zeta inhibitor | 0.105 0.045 DBMET03714 0.136 0.024 DBMET03713 0.087 0.071 DBMET03715 0.123 0.03 DBMET03710 0.094 0.059 DBMET03711 0.113 0.037 DBMET03719 | DBMET03713 | |
| 0.051 | 0.033 | 0.059 | Transforming growth factor beta 1 antagonist | 0.059 0.027 DBMET03719 | DBMET03719 | |
| 0.076 | 0.059 | 0.099 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | 0.074 0.061 DBMET03713 0.082 0.05 DBMET03715 0.083 0.049 DBMET03710 0.099 0.036 DBMET03719 | DBMET03719 | |
| 0.056 | 0.039 | 0.164 | Bruton tyrosine kinase inhibitor | 0.062 0.033 DBMET03709 0.054 0.041 DBMET03713 0.057 0.039 DBMET03715 0.164 0.007 DBMET03710 0.062 0.032 DBMET03712 0.061 0.034 DBMET03711 0.058 0.038 DBMET03719 | DBMET03710 | |
| 0.066 | 0.049 | 0.109 | Nav1.7 sodium channel blocker | 0.076 0.037 DBMET03709 0.06 0.058 DBMET03714 0.08 0.034 DBMET03715 0.109 0.019 DBMET03710 0.096 0.025 DBMET03712 | DBMET03710 | |
| 0.064 | 0.051 | 0.132 | Cyclin B3 inhibitor | 0.132 0.018 DBMET03713 0.068 0.047 DBMET03715 0.06 0.056 DBMET03718 0.108 0.025 DBMET03710 0.105 0.026 DBMET03711 0.067 0.048 DBMET03719 | DBMET03713 | |
| 0.065 | 0.052 | 0.083 | Protein kinase C alpha inhibitor | 0.065 0.052 DBMET03714 0.083 0.032 DBMET03713 0.063 0.055 DBMET03715 0.067 0.049 DBMET03710 0.065 0.052 DBMET03711 0.07 0.045 DBMET03719 | DBMET03713 | |
| 0.055 | 0.045 | 0.09 | Protein kinase C theta inhibitor | 0.09 0.01 DBMET03714 0.06 0.037 DBMET03719 | DBMET03714 | |
| 0.038 | 0.029 | 0.074 | Cathepsin L1 inhibitor | 0.074 0.013 DBMET03714 0.035 0.032 DBMET03719 | DBMET03714 | |
| 0.065 | 0.056 | 0.157 | I kappa B kinase 1 inhibitor | 0.07 0.047 DBMET03713 0.084 0.033 DBMET03715 0.157 0.008 DBMET03718 0.113 0.017 DBMET03710 0.072 0.046 DBMET03712 0.116 0.016 DBMET03719 | DBMET03718 | |
| 0.03 | 0.021 | 0.169 | Dipeptidyl peptidase I inhibitor | 0.169 0.002 DBMET03714 0.03 0.022 DBMET03719 | DBMET03714 | |
| 0.085 | 0.076 | 0.119 | DNA directed RNA polymerase inhibitor | 0.098 0.059 DBMET03714 0.088 0.072 DBMET03718 0.119 0.038 DBMET03719 | DBMET03719 | |
| 0.06 | 0.052 | 0.063 | p38 MAP kinase inhibitor | 0.063 0.049 DBMET03710 | DBMET03710 | |
| 0.079 | 0.072 | 0.087 | T cell inhibitor | 0.085 0.05 DBMET03717 0.081 0.064 DBMET03713 0.079 0.068 DBMET03715 0.087 0.044 DBMET03718 0.087 0.045 DBMET03719 | DBMET03719 | |
| 0.065 | 0.059 | 0.126 | Lipase inhibitor | 0.126 0.015 DBMET03714 0.089 0.034 DBMET03718 0.064 0.06 DBMET03719 | DBMET03714 | |
| 0.067 | 0.063 | 0.076 | MAP-kinase-activated kinase 2 inhibitor | 0.071 0.057 DBMET03713 0.07 0.057 DBMET03710 0.076 0.049 DBMET03719 | DBMET03719 | |
| 0.065 | 0.063 | 0.102 | Rho-associated kinase II inhibitor | 0.071 0.055 DBMET03715 0.093 0.036 DBMET03718 0.071 0.055 DBMET03710 0.102 0.031 DBMET03719 | DBMET03719 | |
| 0.078 | 0.078 | 0.081 | Hepatocyte growth factor antagonist | 0.081 0.073 DBMET03710 | DBMET03710 | |
| 0.126 | 0.127 | 0.3 | LIM domain kinase 1 inhibitor | 0.145 0.103 DBMET03714 0.164 0.085 DBMET03713 0.144 0.104 DBMET03715 0.252 0.037 DBMET03718 0.186 0.07 DBMET03710 0.3 0.021 DBMET03719 | DBMET03719 | |
| 0.104 | 0.106 | 0.118 | Toll-Like receptor 9 antagonist | 0.118 0.088 DBMET03714 | DBMET03714 | |
| 0.06 | 0.062 | 0.088 | CDK2/cyclin E2 inhibitor | 0.071 0.048 DBMET03713 0.079 0.04 DBMET03715 0.086 0.035 DBMET03718 0.075 0.043 DBMET03710 0.088 0.033 DBMET03719 | DBMET03719 | |
| 0.015 | 0.016 | 0.017 | CDK2/cyclin A3 inhibitor | 0.017 0.009 DBMET03719 | DBMET03719 | |
| 0.061 | 0.065 | 0.115 | Rho-associated kinase inhibitor | 0.086 0.042 DBMET03718 0.115 0.029 DBMET03719 | DBMET03719 | |
| 0.011 | 0.016 | 0.018 | Cyclin D2 inhibitor | 0.018 0.004 DBMET03713 0.013 0.01 DBMET03710 0.014 0.009 DBMET03711 | DBMET03713 | |
| 0.075 | 0.08 | 0.09 | Fibroblast growth factor 1 antagonist | 0.09 0.066 DBMET03713 0.085 0.07 DBMET03715 0.089 0.066 DBMET03719 | DBMET03713 | |
| 0.102 | 0.108 | 0.177 | Sodium channel (voltage-gated) blocker | 0.123 0.082 DBMET03709 0.109 0.098 DBMET03714 0.142 0.061 DBMET03715 0.177 0.039 DBMET03710 0.166 0.044 DBMET03712 | DBMET03710 | |
| 0.033 | 0.04 | 0.082 | CDK5/p25 inhibitor | 0.056 0.017 DBMET03713 0.057 0.017 DBMET03718 0.049 0.022 DBMET03710 0.036 0.035 DBMET03711 0.082 0.009 DBMET03719 | DBMET03719 | |
| 0.01 | 0.02 | 0.019 | Egl nine homolog 1 inhibitor | 0.019 0.006 DBMET03717 | DBMET03717 | |
| 0.031 | 0.042 | 0.078 | Vascular adhesion protein 1 inhibitor | 0.078 0.005 DBMET03714 0.046 0.019 DBMET03715 0.046 0.019 DBMET03710 | DBMET03714 | |
| 0.071 | 0.085 | 0.091 | Proto-oncogene tyrosine-protein kinase Kit inhibitor | 0.091 0.062 DBMET03718 0.089 0.064 DBMET03719 | DBMET03718 | |
| 0.051 | 0.066 | 0.084 | Transcription factor AP-1 inhibitor | 0.084 0.019 DBMET03713 0.063 0.04 DBMET03710 0.07 0.03 DBMET03711 | DBMET03713 | |
| 0.056 | 0.072 | 0.095 | Potassium channel (ATP-sensitive) blocker | 0.065 0.049 DBMET03714 0.095 0.018 DBMET03718 0.094 0.018 DBMET03719 | DBMET03718 | |
| 0.08 | 0.096 | 0.155 | Cyclin-dependent kinase 5 inhibitor | 0.107 0.07 DBMET03713 0.151 0.04 DBMET03718 0.113 0.064 DBMET03710 0.155 0.038 DBMET03719 | DBMET03719 | |
| 0.093 | 0.11 | 0.108 | TRKB antagonist | 0.108 0.089 DBMET03719 | DBMET03719 | |
| 0.027 | 0.044 | 0.037 | ATR kinase inhibitor | 0.037 0.016 DBMET03710 | DBMET03710 | |
| 0.04 | 0.058 | 0.102 | Phosphatidylinositol 3-kinase delta inhibitor | 0.066 0.033 DBMET03709 0.102 0.019 DBMET03710 0.062 0.036 DBMET03712 0.062 0.036 DBMET03711 | DBMET03710 | |
| 0.057 | 0.075 | 0.062 | Transforming growth factor antagonist | 0.062 0.061 DBMET03719 | DBMET03719 | |
| 0.031 | 0.053 | 0.454 | Neurokinin 2 agonist | 0.454 0.002 DBMET03714 | DBMET03714 | |
| 0.07 | 0.095 | 0.214 | Check point kinase 2 inhibitor | 0.096 0.069 DBMET03715 0.214 0.014 DBMET03710 0.117 0.051 DBMET03719 | DBMET03710 | |
| 0.018 | 0.047 | 0.058 | Protocollagen prolyl hydroxylase inhibitor | 0.058 0.005 DBMET03717 | DBMET03717 | |
| 0.112 | 0.142 | 0.198 | TRKC antagonist | 0.175 0.082 DBMET03710 0.198 0.068 DBMET03719 | DBMET03719 | |
| 0.144 | 0.178 | 0.181 | MAP kinase kinase 5 inhibitor | 0.164 0.101 DBMET03714 0.181 0.06 DBMET03718 0.179 0.064 DBMET03710 0.176 0.072 DBMET03719 | DBMET03718 | |
| 0.029 | 0.064 | 0.058 | Protein kinase (CK1) epsilon inhibitor | 0.058 0.009 DBMET03710 | DBMET03710 | |
| 0.055 | 0.09 | 0.081 | TIE antagonist | 0.073 0.067 DBMET03713 0.081 0.058 DBMET03710 0.081 0.058 DBMET03719 | DBMET03719 | |
| 0.028 | 0.063 | 0.044 | Proto-oncogene tyrosine-protein kinase Met inhibitor | 0.044 0.038 DBMET03719 | DBMET03719 | |
| 0.069 | 0.104 | 0.094 | Pim-3 kinase inhibitor | 0.088 0.061 DBMET03710 0.094 0.052 DBMET03719 | DBMET03719 | |
| 0.054 | 0.089 | 0.08 | TIE-2 antagonist | 0.072 0.066 DBMET03713 0.08 0.057 DBMET03710 0.079 0.058 DBMET03719 | DBMET03710 | |
| 0.065 | 0.105 | 0.103 | MAP kinase kinase 7 inhibitor | 0.103 0.01 DBMET03714 0.09 0.024 DBMET03713 0.076 0.058 DBMET03718 0.09 0.024 DBMET03710 0.075 0.064 DBMET03711 | DBMET03714 | |
| 0.065 | 0.105 | 0.166 | Protein kinase C delta inhibitor | 0.166 0.015 DBMET03714 0.087 0.067 DBMET03713 0.081 0.074 DBMET03719 | DBMET03714 | |
| 0.034 | 0.077 | 0.071 | Toll-Like receptor 8 antagonist | 0.071 0.023 DBMET03714 | DBMET03714 | |
| 0.02 | 0.064 | 0.043 | MAP3K8 inhibitor | 0.043 0.005 DBMET03714 | DBMET03714 | |
| 0.005 | 0.05 | 0.014 | Egl nine homolog 3 inhibitor | 0.014 0.006 DBMET03713 0.014 0.006 DBMET03711 | DBMET03711 | |
| 0.057 | 0.103 | 0.076 | Potassium channel (Tandem pore domain) blocker | 0.076 0.046 DBMET03714 | DBMET03714 | |
| 0.021 | 0.07 | 0.078 | Histone deacetylase class I inhibitor | 0.078 0.01 DBMET03719 | DBMET03719 | |
| 0.049 | 0.1 | 0.08 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.08 0.05 DBMET03710 | DBMET03710 | |
| 0.084 | 0.136 | 0.13 | Vascular endothelial growth factor 3 antagonist | 0.109 0.107 DBMET03710 0.13 0.084 DBMET03719 | DBMET03719 | |
| 0.043 | 0.098 | 0.056 | Potassium channel (Ca-activated) blocker | 0.056 0.051 DBMET03719 | DBMET03719 | |
| 0.072 | 0.128 | 0.148 | Toll-Like receptor 3 antagonist | 0.11 0.038 DBMET03714 0.087 0.076 DBMET03715 0.148 0.015 DBMET03719 | DBMET03719 | |
| 0.043 | 0.107 | 0.098 | Protein kinase C beta inhibitor | 0.075 0.038 DBMET03714 0.098 0.014 DBMET03713 0.077 0.035 DBMET03710 0.082 0.027 DBMET03711 | DBMET03713 | |
| 0.041 | 0.107 | 0.079 | Heat shock protein 90 beta antagonist | 0.079 0.021 DBMET03714 | DBMET03714 | |
| 0.031 | 0.101 | 0.052 | Pim-2 kinase inhibitor | 0.052 0.043 DBMET03719 | DBMET03719 | |
| 0.023 | 0.096 | 0.035 | Protein kinase C beta I inhibitor | 0.035 0.019 DBMET03713 0.033 0.026 DBMET03711 | DBMET03713 | |
| 0.063 | 0.136 | 0.093 | mTOR complex 2 inhibitor | 0.08 0.07 DBMET03714 0.087 0.052 DBMET03713 0.093 0.042 DBMET03710 | DBMET03710 | |
| 0.154 | 0.229 | 0.213 | Immunomodulator | 0.199 0.166 DBMET03713 0.194 0.172 DBMET03715 0.209 0.154 DBMET03718 0.213 0.149 DBMET03710 0.184 0.183 DBMET03711 0.204 0.159 DBMET03719 | DBMET03710 | |
| 0.055 | 0.131 | 0.098 | Pim-1 kinase inhibitor | 0.098 0.06 DBMET03713 0.088 0.07 DBMET03719 | DBMET03713 | |
| 0.146 | 0.226 | 0.253 | Nitric-oxide synthase stimulant | 0.253 0.031 DBMET03714 0.172 0.148 DBMET03718 0.208 0.076 DBMET03719 | DBMET03714 | |
| 0.031 | 0.111 | 0.048 | Factor IXa inhibitor | 0.048 0.041 DBMET03713 0.046 0.044 DBMET03711 | DBMET03713 | |
| 0.019 | 0.1 | 0.033 | Protein kinase C beta II inhibitor | 0.033 0.022 DBMET03713 0.032 0.024 DBMET03711 | DBMET03713 | |
| 0.156 | 0.239 | 0.351 | Insulysin inhibitor | 0.196 0.164 DBMET03717 0.351 0.034 DBMET03714 0.224 0.124 DBMET03713 0.282 0.07 DBMET03715 0.217 0.133 DBMET03712 | DBMET03714 | |
| 0.046 | 0.133 | 0.077 | Protein kinase A inhibitor | 0.077 0.063 DBMET03719 | DBMET03719 | |
| 0.005 | 0.097 | 0.025 | Cyclin T1 inhibitor | 0.025 0.007 DBMET03714 | DBMET03714 | |
| 0.028 | 0.12 | 0.055 | Protein kinase C eta inhibitor | 0.055 0.038 DBMET03713 | DBMET03713 | |
| 0.055 | 0.149 | 0.085 | Breast cancer-resistant protein inhibitor | 0.085 0.073 DBMET03719 | DBMET03719 | |
| 0.026 | 0.122 | 0.086 | Histamine agonist | 0.086 0.012 DBMET03714 | DBMET03714 | |
| 0.052 | 0.148 | 0.11 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.11 0.03 DBMET03713 0.09 0.049 DBMET03718 0.099 0.039 DBMET03711 | DBMET03713 | |
| 0.071 | 0.172 | 0.13 | Sodium channel blocker | 0.118 0.086 DBMET03715 0.13 0.074 DBMET03710 0.128 0.076 DBMET03712 | DBMET03710 | |
| 0.088 | 0.189 | 0.139 | DNA repair enzyme inhibitor | 0.139 0.042 DBMET03714 | DBMET03714 | |
| 0.071 | 0.172 | 0.115 | Folate antagonist | 0.115 0.044 DBMET03717 0.092 0.081 DBMET03718 0.102 0.06 DBMET03719 | DBMET03717 | |
| 0.012 | 0.114 | 0.06 | Diamine oxidase inhibitor | 0.06 0.01 DBMET03714 0.057 0.011 DBMET03715 | DBMET03714 | |
| 0.008 | 0.113 | 0.025 | Cyclin E2 inhibitor | 0.025 0.023 DBMET03710 | DBMET03710 | |
| 0.018 | 0.133 | 0.069 | Thymidylate synthase inhibitor | 0.069 0.012 DBMET03717 0.052 0.025 DBMET03714 0.061 0.016 DBMET03719 | DBMET03717 | |
| 0.157 | 0.274 | 0.527 | GABA C receptor rho-3 antagonist | 0.527 0.019 DBMET03714 0.375 0.073 DBMET03719 | DBMET03714 | |
| 0.019 | 0.145 | 0.036 | Tryptophan 5 hydroxylase inhibitor | 0.036 0.024 DBMET03714 | DBMET03714 | |
| 0.105 | 0.233 | 0.132 | CC chemokine 6 receptor antagonist | 0.132 0.063 DBMET03713 0.123 0.104 DBMET03710 0.131 0.068 DBMET03711 | DBMET03713 | |
| 0.069 | 0.199 | 0.123 | Toll-Like receptor antagonist | 0.123 0.08 DBMET03714 | DBMET03714 | |
| 0.089 | 0.221 | 0.166 | Potassium channel blocker | 0.166 0.119 DBMET03710 | DBMET03710 | |
| 0.028 | 0.166 | 0.079 | Histone deacetylase inhibitor | 0.079 0.031 DBMET03719 | DBMET03719 | |
| 0.011 | 0.149 | 0.02 | Toll-Like receptor 8 agonist | 0.02 0.015 DBMET03714 | DBMET03714 | |
| 0.037 | 0.176 | 0.085 | Phosphodiesterase 3A inhibitor | 0.085 0.048 DBMET03710 0.081 0.054 DBMET03711 | DBMET03710 | |
| 0.018 | 0.161 | 0.047 | Protein kinase (CK2) beta inhibitor | 0.047 0.008 DBMET03713 0.037 0.016 DBMET03711 | DBMET03713 | |
| 0.02 | 0.168 | 0.06 | Diacylglycerol O-acyltransferase inhibitor | 0.06 0.026 DBMET03713 0.047 0.041 DBMET03711 | DBMET03713 | |
| 0.055 | 0.206 | 0.149 | Bone formation stimulant | 0.149 0.06 DBMET03717 0.104 0.102 DBMET03718 | DBMET03717 | |
| 0.064 | 0.225 | 0.123 | Interleukin 4 antagonist | 0.123 0.081 DBMET03713 | DBMET03713 | |
| 0.016 | 0.178 | 0.104 | Histamine H2 receptor agonist | 0.104 0.004 DBMET03714 0.05 0.021 DBMET03719 | DBMET03714 | |
| 0.005 | 0.169 | 0.025 | Histamine H4 receptor agonist | 0.025 0.008 DBMET03714 | DBMET03714 | |
| 0.183 | 0.348 | 0.418 | Caspase 9 stimulant | 0.418 0.101 DBMET03714 0.256 0.245 DBMET03713 | DBMET03714 | |
| 0.187 | 0.353 | 0.33 | Antiinflammatory | 0.33 0.189 DBMET03713 0.307 0.209 DBMET03711 | DBMET03713 | |
| 0.016 | 0.188 | 0.036 | Glutamate (mGluR1a) antagonist | 0.036 0.034 DBMET03714 | DBMET03714 | |
| 0.028 | 0.2 | 0.077 | Phospholipase D inhibitor | 0.077 0.039 DBMET03714 | DBMET03714 | |
| 0.013 | 0.19 | 0.082 | Cannabinoid CB1 receptor agonist | 0.082 0.027 DBMET03714 | DBMET03714 | |
| 0.046 | 0.239 | 0.094 | DNA polymerase I inhibitor | 0.094 0.092 DBMET03713 | DBMET03713 | |
| 0.023 | 0.216 | 0.062 | 5 Hydroxytryptamine 1B agonist | 0.062 0.025 DBMET03714 | DBMET03714 | |
| 0.073 | 0.268 | 0.11 | Sphingosine 1-phosphate receptor 2 agonist | 0.11 0.075 DBMET03718 | DBMET03718 | |
| 0.075 | 0.27 | 0.199 | GABA C receptor rho-2 antagonist | 0.199 0.03 DBMET03714 0.129 0.107 DBMET03719 | DBMET03714 | |
| 0.079 | 0.277 | 0.201 | Tumour necrosis factor antagonist | 0.201 0.053 DBMET03710 0.131 0.125 DBMET03711 0.146 0.106 DBMET03719 | DBMET03710 | |
| 0.057 | 0.256 | 0.137 | Acetylcholine release stimulant | 0.137 0.027 DBMET03714 | DBMET03714 | |
| 0.033 | 0.243 | 0.148 | Falcipain 3 inhibitor | 0.148 0.037 DBMET03714 | DBMET03714 | |
| 0.023 | 0.235 | 0.047 | Topoisomerase II beta inhibitor | 0.047 0.038 DBMET03714 | DBMET03714 | |
| 0.033 | 0.248 | 0.057 | Gonadotropin-releasing hormone receptor agonist | 0.057 0.047 DBMET03715 | DBMET03715 | |
| 0.046 | 0.261 | 0.105 | Granulocyte macrophage colony stimulating factor agonist | 0.105 0.029 DBMET03714 | DBMET03714 | |
| 0.017 | 0.239 | 0.063 | Phosphodiesterase 4B inhibitor | 0.063 0.052 DBMET03710 | DBMET03710 | |
| 0.009 | 0.231 | 0.081 | Factor VIIa inhibitor | 0.074 0.014 DBMET03710 0.081 0.014 DBMET03712 0.043 0.023 DBMET03711 | DBMET03712 | |
| 0.05 | 0.276 | 0.153 | Aryl hydrocarbon receptor agonist | 0.153 0.133 DBMET03713 0.146 0.138 DBMET03719 | DBMET03713 | |
| 0.02 | 0.251 | 0.056 | Potassium channel (ATP-sensitive) activator | 0.056 0.021 DBMET03714 | DBMET03714 | |
| 0.021 | 0.256 | 0.059 | Potassium channel (Inward rectifier) activator | 0.059 0.021 DBMET03714 | DBMET03714 | |
| 0.058 | 0.294 | 0.139 | Heat shock protein 90 antagonist | 0.139 0.087 DBMET03710 | DBMET03710 | |
| 0.001 | 0.239 | 0.007 | CC chemokine 6 receptor agonist | 0.007 0.004 DBMET03714 | DBMET03714 | |
| 0.02 | 0.258 | 0.061 | Sphingosine kinase 2 inhibitor | 0.061 0.031 DBMET03714 | DBMET03714 | |
| 0.068 | 0.31 | 0.208 | Hemostatic | 0.208 0.029 DBMET03714 0.137 0.084 DBMET03710 0.15 0.068 DBMET03712 0.139 0.083 DBMET03711 0.126 0.103 DBMET03719 | DBMET03714 | |
| 0.016 | 0.263 | 0.038 | Thymidine kinase inhibitor | 0.038 0.033 DBMET03714 | DBMET03714 | |
| 0.049 | 0.298 | 0.125 | Interleukin 1 antagonist | 0.125 0.082 DBMET03713 | DBMET03713 | |
| 0.057 | 0.307 | 0.125 | Heat shock protein 90 alpha antagonist | 0.125 0.119 DBMET03710 | DBMET03710 | |
| 0.035 | 0.285 | 0.084 | Aminoacyl-tRNA synthetase inhibitor | 0.084 0.068 DBMET03714 | DBMET03714 | |
| 0.052 | 0.303 | 0.146 | Interleukin 8 antagonist | 0.115 0.069 DBMET03714 0.119 0.062 DBMET03713 0.104 0.088 DBMET03718 0.146 0.037 DBMET03719 | DBMET03719 | |
| 0.015 | 0.273 | 0.036 | Nicotinic acid receptor 1 agonist | 0.036 0.034 DBMET03713 | DBMET03713 | |
| 0.016 | 0.276 | 0.043 | Potassium channel Kv1.1 blocker | 0.043 0.019 DBMET03714 | DBMET03714 | |
| 0.017 | 0.279 | 0.047 | Histamine H4 receptor antagonist | 0.047 0.036 DBMET03714 | DBMET03714 | |
| 0.004 | 0.266 | 0.021 | Dipeptidyl peptidase IX inhibitor | 0.021 0.008 DBMET03714 | DBMET03714 | |
| 0.019 | 0.28 | 0.065 | Lysine-specific demethylase 1A inhibitor | 0.065 0.022 DBMET03714 | DBMET03714 | |
| 0.031 | 0.298 | 0.066 | Histone deacetylase SIRT3 inhibitor | 0.066 0.035 DBMET03714 | DBMET03714 | |
| 0.059 | 0.335 | 0.266 | Antiamyloidogenic | 0.227 0.083 DBMET03713 0.2 0.099 DBMET03715 0.242 0.074 DBMET03712 0.266 0.064 DBMET03711 | DBMET03711 | |
| 0.019 | 0.302 | 0.122 | Dipeptidyl peptidase inhibitor | 0.122 0.006 DBMET03714 | DBMET03714 | |
| 0.016 | 0.303 | 0.056 | Cytokine production stimulant | 0.056 0.018 DBMET03714 | DBMET03714 | |
| 0.008 | 0.297 | 0.047 | Urokinase inhibitor | 0.047 0.034 DBMET03714 | DBMET03714 | |
| 0.046 | 0.337 | 0.117 | Nav1.2 sodium channel blocker | 0.117 0.086 DBMET03714 | DBMET03714 | |
| 0.02 | 0.32 | 0.114 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.114 0.007 DBMET03714 0.078 0.042 DBMET03719 | DBMET03714 | |
| 0.006 | 0.31 | 0.06 | Dihydropteroate synthase inhibitor | 0.06 0.011 DBMET03714 0.042 0.024 DBMET03719 | DBMET03714 | |
| 0.011 | 0.32 | 0.055 | Alpha 2 adrenoreceptor agonist | 0.055 0.049 DBMET03714 | DBMET03714 | |
| 0.064 | 0.375 | 0.265 | DNA damaging | 0.265 0.072 DBMET03714 | DBMET03714 | |
| 0.016 | 0.33 | 0.054 | CXC chemokine 4 receptor antagonist | 0.054 0.047 DBMET03714 | DBMET03714 | |
| 0.106 | 0.422 | 0.358 | Tyrosine 3 hydroxylase inhibitor | 0.358 0.014 DBMET03714 | DBMET03714 | |
| 0.005 | 0.322 | 0.072 | Glutamate (mGluR1) antagonist | 0.072 0.028 DBMET03714 | DBMET03714 | |
| 0.029 | 0.348 | 0.1 | AMP-activated protein kinase stimulant | 0.1 0.07 DBMET03713 | DBMET03713 | |
| 0.002 | 0.322 | 0.014 | CXC chemokine 4 receptor agonist | 0.014 0.013 DBMET03714 | DBMET03714 | |
| 0.129 | 0.455 | 0.389 | 5 Hydroxytryptamine release inhibitor | 0.389 0.085 DBMET03714 0.389 0.085 DBMET03713 0.245 0.235 DBMET03710 0.3 0.165 DBMET03711 | DBMET03713 | |
| 0.003 | 0.329 | 0.018 | Alpha 2a adrenoreceptor agonist | 0.018 0.012 DBMET03714 | DBMET03714 | |
| 0.003 | 0.333 | 0.03 | 5 Hydroxytryptamine 1D agonist | 0.03 0.019 DBMET03714 | DBMET03714 | |
| 0.009 | 0.34 | 0.052 | Xanthine dehydrogenase inhibitor | 0.052 0.044 DBMET03713 | DBMET03713 | |
| 0.013 | 0.345 | 0.095 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.095 0.015 DBMET03714 | DBMET03714 | |
| 0.019 | 0.351 | 0.072 | Secretase beta inhibitor | 0.072 0.046 DBMET03714 | DBMET03714 | |
| 0.013 | 0.347 | 0.044 | AICAR transformylase inhibitor | 0.044 0.03 DBMET03714 | DBMET03714 | |
| 0.03 | 0.365 | 0.243 | GABA C receptor rho-1 antagonist | 0.243 0.005 DBMET03714 | DBMET03714 | |
| 0.113 | 0.452 | 0.286 | 5 Hydroxytryptamine 3E antagonist | 0.286 0.006 DBMET03714 | DBMET03714 | |
| 0.004 | 0.349 | 0.027 | Methionyl aminopeptidase 2 inhibitor | 0.027 0.016 DBMET03713 | DBMET03713 | |
| 0.01 | 0.357 | 0.041 | Dihydroorotase inhibitor | 0.041 0.036 DBMET03714 | DBMET03714 | |
| 0.067 | 0.417 | 0.486 | Superoxide dismutase inhibitor | 0.486 0.014 DBMET03714 0.228 0.09 DBMET03713 | DBMET03714 | |
| 0.032 | 0.383 | 0.198 | Cathepsin H inhibitor | 0.198 0.023 DBMET03714 | DBMET03714 | |
| 0.004 | 0.361 | 0.018 | Dipeptidyl peptidase VIII inhibitor | 0.018 0.009 DBMET03714 | DBMET03714 | |
| 0.01 | 0.368 | 0.061 | Somatostatin 5 agonist | 0.061 0.009 DBMET03714 | DBMET03714 | |
| 0.006 | 0.364 | 0.04 | Factor Xa inhibitor | 0.04 0.037 DBMET03712 | DBMET03712 | |
| 0.015 | 0.381 | 0.045 | CC chemokine 4 receptor antagonist | 0.045 0.037 DBMET03714 | DBMET03714 | |
| 0.072 | 0.438 | 0.246 | Gastrin inhibitor | 0.246 0.084 DBMET03714 0.181 0.177 DBMET03713 | DBMET03714 | |
| 0.004 | 0.371 | 0.04 | Lysine carboxypeptidase inhibitor | 0.04 0.01 DBMET03714 | DBMET03714 | |
| 0.028 | 0.396 | 0.058 | Immunoglobulin Fc receptor antagonist | 0.058 0.03 DBMET03714 | DBMET03714 | |
| 0.039 | 0.411 | 0.484 | Peroxidase inhibitor | 0.484 0.011 DBMET03714 | DBMET03714 | |
| 0.033 | 0.407 | 0.139 | Toll-Like receptor 2 antagonist | 0.139 0.061 DBMET03714 | DBMET03714 | |
| 0.034 | 0.409 | 0.137 | Lanosterol 14 alpha demethylase inhibitor | 0.137 0.017 DBMET03714 | DBMET03714 | |
| 0.079 | 0.456 | 0.493 | Histamine release inhibitor | 0.231 0.17 DBMET03714 0.493 0.031 DBMET03713 0.425 0.063 DBMET03711 | DBMET03713 | |
| 0.03 | 0.41 | 0.073 | Transcription factor RelA inhibitor | 0.073 0.025 DBMET03714 | DBMET03714 | |
| 0.014 | 0.395 | 0.069 | Epithelial sodium channel blocker | 0.069 0.019 DBMET03714 | DBMET03714 | |
| 0.004 | 0.387 | 0.051 | Factor X inhibitor | 0.049 0.022 DBMET03710 0.051 0.021 DBMET03712 | DBMET03712 | |
| 0.021 | 0.415 | 0.365 | GABA C receptor antagonist | 0.365 0.004 DBMET03714 | DBMET03714 | |
| 0.025 | 0.42 | 0.106 | GABA receptor agonist | 0.106 0.07 DBMET03714 | DBMET03714 | |
| 0.037 | 0.432 | 0.415 | Interleukin antagonist | 0.415 0.029 DBMET03715 0.336 0.041 DBMET03712 | DBMET03715 | |
| 0.003 | 0.399 | 0.044 | Carbonic anhydrase IV inhibitor | 0.044 0.029 DBMET03714 | DBMET03714 | |
| 0.02 | 0.419 | 0.051 | Parathyroid hormone antagonist | 0.051 0.02 DBMET03714 | DBMET03714 | |
| 0.043 | 0.443 | 0.179 | Hexokinase inhibitor | 0.179 0.05 DBMET03713 0.136 0.096 DBMET03711 | DBMET03713 | |
| 0.052 | 0.453 | 0.293 | Phospholipase C inhibitor | 0.293 0.019 DBMET03714 | DBMET03714 | |
| 0.039 | 0.445 | 0.102 | Estrogen-related receptor beta agonist | 0.102 0.023 DBMET03714 | DBMET03714 | |
| 0.037 | 0.446 | 0.17 | Neuropeptide Y1 antagonist | 0.17 0.039 DBMET03714 | DBMET03714 | |
| 0.011 | 0.423 | 0.086 | Dipeptidyl peptidase IV inhibitor | 0.086 0.007 DBMET03714 | DBMET03714 | |
| 0.022 | 0.44 | 0.209 | 5 Hydroxytryptamine 3A agonist | 0.209 0.012 DBMET03714 | DBMET03714 | |
| 0.01 | 0.439 | 0.091 | Aconitate hydratase inhibitor | 0.091 0.01 DBMET03714 0.049 0.04 DBMET03713 | DBMET03714 | |
| 0.02 | 0.454 | 0.097 | Histamine H2 receptor antagonist | 0.097 0.037 DBMET03714 | DBMET03714 | |
| 0.008 | 0.447 | 0.029 | Estrogen-related receptor gamma antagonist | 0.029 0.017 DBMET03714 | DBMET03714 | |
| 0.017 | 0.458 | 0.145 | Histamine N-methyltransferase inhibitor | 0.145 0.016 DBMET03714 | DBMET03714 | |
| 0.002 | 0.449 | 0.051 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.051 0.009 DBMET03714 | DBMET03714 | |
| 0.064 | 0.512 | 0.189 | Neurotensin receptor agonist | 0.189 0.041 DBMET03714 | DBMET03714 | |
| 0.014 | 0.462 | 0.055 | Aldosterone antagonist | 0.055 0.024 DBMET03714 | DBMET03714 | |
| 0.003 | 0.454 | 0.047 | Sirtuin 2 inhibitor | 0.047 0.014 DBMET03714 | DBMET03714 | |
| 0.014 | 0.469 | 0.063 | Botulinum neurotoxin type A inhibitor | 0.063 0.033 DBMET03714 | DBMET03714 | |
| 0.031 | 0.489 | 0.178 | Calpain inhibitor | 0.178 0.137 DBMET03714 | DBMET03714 | |
| 0.004 | 0.463 | 0.051 | Guanylate cyclase inhibitor | 0.051 0.02 DBMET03714 | DBMET03714 | |
| 0.004 | 0.468 | 0.115 | Kinesin antagonist | 0.115 0.006 DBMET03714 | DBMET03714 | |
| 0.004 | 0.468 | 0.115 | Kinesin-like protein 1 inhibitor | 0.115 0.006 DBMET03714 | DBMET03714 | |
| 0.003 | 0.466 | 0.033 | Nicotinic alpha4beta2 receptor agonist | 0.033 0.014 DBMET03714 | DBMET03714 | |
| 0.003 | 0.47 | 0.024 | Imidazoline I1 receptor antagonist | 0.024 0.01 DBMET03714 | DBMET03714 | |
| 0.03 | 0.498 | 0.156 | Carbonic anhydrase XV inhibitor | 0.156 0.029 DBMET03714 0.091 0.082 DBMET03713 | DBMET03714 | |
| 0.025 | 0.497 | 0.132 | Carbonic anhydrase III inhibitor | 0.132 0.037 DBMET03714 0.088 0.077 DBMET03713 | DBMET03714 | |
| 0.004 | 0.476 | 0.048 | AMPA receptor antagonist | 0.048 0.033 DBMET03714 | DBMET03714 | |
| 0.017 | 0.49 | 0.101 | Myeloperoxidase inhibitor | 0.101 0.034 DBMET03714 | DBMET03714 | |
| 0.003 | 0.478 | 0.07 | Phosphoglycerate kinase inhibitor | 0.07 0.01 DBMET03714 | DBMET03714 | |
| 0.025 | 0.5 | 0.097 | Vanilloid 4 agonist | 0.097 0.019 DBMET03714 | DBMET03714 | |
| 0.023 | 0.499 | 0.284 | Anticoagulant | 0.167 0.068 DBMET03709 0.263 0.036 DBMET03710 0.284 0.031 DBMET03712 0.223 0.045 DBMET03711 | DBMET03712 | |
| 0.037 | 0.513 | 0.264 | Interleukin agonist | 0.264 0.069 DBMET03714 0.174 0.145 DBMET03713 | DBMET03714 | |
| 0.006 | 0.483 | 0.031 | Calcitonin receptor agonist | 0.031 0.026 DBMET03714 | DBMET03714 | |
| 0.032 | 0.511 | 0.102 | D-Ala-D-Ala ligase inhibitor | 0.102 0.027 DBMET03714 | DBMET03714 | |
| 0.01 | 0.49 | 0.03 | Hedgehog signaling activator | 0.03 0.012 DBMET03714 | DBMET03714 | |
| 0.011 | 0.495 | 0.08 | Carbonic anhydrase stimulant | 0.08 0.026 DBMET03714 | DBMET03714 | |
| 0.017 | 0.502 | 0.053 | Bombesin 2 receptor antagonist | 0.053 0.03 DBMET03714 | DBMET03714 | |
| 0.026 | 0.514 | 0.117 | Nav1.4 sodium channel blocker | 0.117 0.054 DBMET03714 | DBMET03714 | |
| 0.011 | 0.502 | 0.218 | CYP2A6 inhibitor | 0.218 0.006 DBMET03714 | DBMET03714 | |
| 0.008 | 0.5 | 0.356 | Porphobilinogen synthase inhibitor | 0.356 0.004 DBMET03714 0.064 0.063 DBMET03713 | DBMET03714 | |
| 0.006 | 0.5 | 0.067 | Histamine H1 receptor agonist | 0.067 0.005 DBMET03714 | DBMET03714 | |
| 0.002 | 0.497 | 0.036 | Nicotinic alpha3beta4 receptor agonist | 0.036 0.014 DBMET03714 | DBMET03714 | |
| 0.019 | 0.521 | 0.11 | Exportin-1 inhibitor | 0.11 0.006 DBMET03714 | DBMET03714 | |
| 0.01 | 0.515 | 0.153 | Alkylator | 0.153 0.045 DBMET03714 | DBMET03714 | |
| 0.004 | 0.51 | 0.099 | MAO B inhibitor | 0.099 0.06 DBMET03714 | DBMET03714 | |
| 0.03 | 0.538 | 0.134 | Glutamate (mGluR7) agonist | 0.134 0.019 DBMET03714 | DBMET03714 | |
| 0.016 | 0.528 | 0.068 | Corticotropin releasing factor 2 receptor antagonist | 0.068 0.031 DBMET03714 | DBMET03714 | |
| 0.026 | 0.539 | 0.141 | TRPA1 agonist | 0.141 0.038 DBMET03714 | DBMET03714 | |
| 0.043 | 0.564 | 0.248 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.248 0.043 DBMET03714 | DBMET03714 | |
| 0.007 | 0.531 | 0.114 | MAO inhibitor | 0.114 0.078 DBMET03714 | DBMET03714 | |
| 0.029 | 0.554 | 0.296 | DNA synthesis inhibitor | 0.296 0.045 DBMET03714 0.203 0.118 DBMET03713 | DBMET03714 | |
| 0.014 | 0.544 | 0.075 | Dihydroorotate oxidase inhibitor | 0.075 0.013 DBMET03714 | DBMET03714 | |
| 0.044 | 0.579 | 0.096 | Factor V inhibitor | 0.096 0.078 DBMET03714 | DBMET03714 | |
| 0.016 | 0.552 | 0.147 | Chelator | 0.147 0.036 DBMET03717 | DBMET03717 | |
| 0.005 | 0.544 | 0.071 | Androgen agonist | 0.071 0.03 DBMET03714 | DBMET03714 | |
| 0.004 | 0.543 | 0.045 | Purinergic P2Y15 antagonist | 0.045 0.005 DBMET03714 | DBMET03714 | |
| 0.005 | 0.553 | 0.527 | Alcohol oxidase inhibitor | 0.527 0.004 DBMET03714 | DBMET03714 | |
| 0.018 | 0.566 | 0.127 | Mannose-6-phosphate isomerase inhibitor | 0.127 0.089 DBMET03714 | DBMET03714 | |
| 0.007 | 0.556 | 0.175 | Phenylalanine 4-hydroxylase inhibitor | 0.175 0.009 DBMET03714 | DBMET03714 | |
| 0.006 | 0.556 | 0.045 | Prolyl endopeptidase inhibitor | 0.045 0.044 DBMET03714 | DBMET03714 | |
| 0.008 | 0.56 | 0.059 | Adenosine deaminase inhibitor | 0.059 0.022 DBMET03714 | DBMET03714 | |
| 0.037 | 0.59 | 0.159 | Glutamate release inhibitor | 0.159 0.008 DBMET03714 | DBMET03714 | |
| 0.011 | 0.564 | 0.077 | Protease 3C (Human rhinovirus) inhibitor | 0.077 0.029 DBMET03714 | DBMET03714 | |
| 0.009 | 0.567 | 0.086 | Dopamine beta hydroxylase inhibitor | 0.086 0.004 DBMET03714 | DBMET03714 | |
| 0.002 | 0.56 | 0.017 | Complement factor D inhibitor | 0.017 0.015 DBMET03714 | DBMET03714 | |
| 0.003 | 0.562 | 0.032 | 5 Hydroxytryptamine 6 agonist | 0.032 0.014 DBMET03714 | DBMET03714 | |
| 0.03 | 0.59 | 0.232 | Transcription factor STAT3 inhibitor | 0.232 0.1 DBMET03714 | DBMET03714 | |
| 0.022 | 0.582 | 0.21 | NADH dehydrogenase inhibitor | 0.21 0.01 DBMET03714 | DBMET03714 | |
| 0.01 | 0.57 | 0.092 | Urease inhibitor | 0.092 0.076 DBMET03714 | DBMET03714 | |
| 0.031 | 0.592 | 0.17 | Cyclic AMP phosphodiesterase inhibitor | 0.17 0.122 DBMET03714 | DBMET03714 | |
| 0.019 | 0.583 | 0.119 | Electrolyte absorption antagonist | 0.119 0.037 DBMET03714 | DBMET03714 | |
| 0.01 | 0.575 | 0.076 | Glutamate (mGluR7) antagonist | 0.076 0.033 DBMET03714 | DBMET03714 | |
| 0.015 | 0.582 | 0.191 | Prolactin inhibitor | 0.191 0.01 DBMET03714 | DBMET03714 | |
| 0.008 | 0.576 | 0.058 | 5 Hydroxytryptamine 7 agonist | 0.058 0.035 DBMET03714 | DBMET03714 | |
| 0.044 | 0.613 | 0.325 | Vasodilator, coronary | 0.325 0.069 DBMET03714 | DBMET03714 | |
| 0.003 | 0.572 | 0.025 | Myristoyl transferase inhibitor | 0.025 0.023 DBMET03714 | DBMET03714 | |
| 0.007 | 0.58 | 0.027 | Thrombin receptor antagonist | 0.027 0.021 DBMET03714 | DBMET03714 | |
| 0.011 | 0.587 | 0.076 | 5 Hydroxytryptamine 3 agonist | 0.076 0.03 DBMET03714 | DBMET03714 | |
| 0.009 | 0.588 | 0.131 | Aminopeptidase I inhibitor | 0.131 0.016 DBMET03714 | DBMET03714 | |
| 0.034 | 0.616 | 0.249 | Neuropeptide Y2 antagonist | 0.249 0.057 DBMET03714 | DBMET03714 | |
| 0.019 | 0.601 | 0.067 | MDM2 inhibitor | 0.067 0.047 DBMET03714 | DBMET03714 | |
| 0.034 | 0.616 | 0.147 | Neurotrophic factor enhancer | 0.147 0.142 DBMET03714 | DBMET03714 | |
| 0.011 | 0.602 | 0.069 | Interferon inducer | 0.069 0.037 DBMET03714 | DBMET03714 | |
| 0.016 | 0.607 | 0.115 | Somatostatin 1 agonist | 0.115 0.026 DBMET03714 | DBMET03714 | |
| 0.025 | 0.618 | 0.113 | Histone deacetylase SIRT1 inhibitor | 0.113 0.1 DBMET03714 | DBMET03714 | |
| 0.071 | 0.668 | 0.156 | Heat shock protein 70 antagonist | 0.156 0.033 DBMET03714 | DBMET03714 | |
| 0.016 | 0.614 | 0.084 | Carbonic anhydrase VI inhibitor | 0.084 0.052 DBMET03714 | DBMET03714 | |
| 0.002 | 0.602 | 0.046 | Endothelial nitric-oxide synthase inhibitor | 0.046 0.011 DBMET03714 | DBMET03714 | |
| 0.054 | 0.657 | 0.392 | Calcium channel activator | 0.392 0.028 DBMET03714 | DBMET03714 | |
| 0.027 | 0.632 | 0.139 | ATPase inhibitor | 0.139 0.122 DBMET03714 | DBMET03714 | |
| 0.008 | 0.615 | 0.124 | Alcohol dehydrogenase inhibitor | 0.124 0.032 DBMET03714 | DBMET03714 | |
| 0.004 | 0.613 | 0.079 | Acetylcholine M5 receptor agonist | 0.079 0.035 DBMET03714 | DBMET03714 | |
| 0.013 | 0.623 | 0.061 | Purinergic P2X1 antagonist | 0.061 0.042 DBMET03714 | DBMET03714 | |
| 0.053 | 0.663 | 0.577 | 5 Hydroxytryptamine release stimulant | 0.577 0.017 DBMET03714 | DBMET03714 | |
| 0.004 | 0.616 | 0.052 | Dipeptidyl peptidase II inhibitor | 0.052 0.009 DBMET03714 | DBMET03714 | |
| 0.011 | 0.623 | 0.072 | Cathepsin G inhibitor | 0.072 0.051 DBMET03714 | DBMET03714 | |
| 0.014 | 0.633 | 0.353 | Alpha-N-acetylglucosaminidase inhibitor | 0.353 0.012 DBMET03714 0.104 0.096 DBMET03713 | DBMET03714 | |
| 0.019 | 0.64 | 0.234 | Succinate dehydrogenase inhibitor | 0.234 0.028 DBMET03714 0.14 0.133 DBMET03713 | DBMET03714 | |
| 0.011 | 0.632 | 0.165 | Creatine kinase inhibitor | 0.165 0.018 DBMET03714 | DBMET03714 | |
| 0.014 | 0.637 | 0.091 | Keratolytic | 0.091 0.036 DBMET03714 | DBMET03714 | |
| 0.011 | 0.636 | 0.612 | GABA C receptor agonist | 0.612 0.003 DBMET03714 | DBMET03714 | |
| 0.009 | 0.635 | 0.036 | Vanilloid 3 antagonist | 0.036 0.035 DBMET03714 | DBMET03714 | |
| 0.012 | 0.641 | 0.181 | UDP-glucose 4-epimerase inhibitor | 0.181 0.021 DBMET03714 | DBMET03714 | |
| 0.003 | 0.632 | 0.022 | Neuraminidase (Influenza B) inhibitor | 0.022 0.013 DBMET03714 | DBMET03714 | |
| 0.022 | 0.654 | 0.138 | Photosensitizer | 0.138 0.039 DBMET03714 | DBMET03714 | |
| 0.022 | 0.655 | 0.151 | Melanin inhibitor | 0.151 0.08 DBMET03714 | DBMET03714 | |
| 0.011 | 0.644 | 0.07 | Carbonic anhydrase XIII inhibitor | 0.07 0.058 DBMET03714 | DBMET03714 | |
| 0.018 | 0.653 | 0.213 | Cell wall synthesis inhibitor | 0.213 0.025 DBMET03714 | DBMET03714 | |
| 0.005 | 0.64 | 0.043 | Somatostatin 1 antagonist | 0.043 0.024 DBMET03714 | DBMET03714 | |
| 0.007 | 0.645 | 0.054 | Maillard reaction inhibitor | 0.054 0.039 DBMET03714 | DBMET03714 | |
| 0.007 | 0.645 | 0.029 | Complement factor 1s inhibitor | 0.029 0.01 DBMET03714 | DBMET03714 | |
| 0.009 | 0.648 | 0.084 | Interferon agonist | 0.084 0.047 DBMET03714 | DBMET03714 | |
| 0.017 | 0.657 | 0.187 | Aldehyde dehydrogenase inhibitor | 0.187 0.031 DBMET03714 | DBMET03714 | |
| 0.011 | 0.652 | 0.309 | Ferrochelatase inhibitor | 0.309 0.007 DBMET03714 0.089 0.084 DBMET03713 | DBMET03714 | |
| 0.008 | 0.65 | 0.241 | Anesthetic general | 0.241 0.054 DBMET03714 | DBMET03714 | |
| 0.019 | 0.661 | 0.478 | Aldehyde oxidase inhibitor | 0.478 0.036 DBMET03714 | DBMET03714 | |
| 0.069 | 0.719 | 0.302 | Peptidyltransferase inhibitor | 0.172 0.142 DBMET03717 0.302 0.024 DBMET03714 | DBMET03714 | |
| 0.005 | 0.656 | 0.02 | Methylmalonyl-CoA mutase inhibitor | 0.02 0.009 DBMET03714 | DBMET03714 | |
| 0.008 | 0.661 | 0.065 | Glucose-6-phosphate isomerase inhibitor | 0.065 0.015 DBMET03714 | DBMET03714 | |
| 0.006 | 0.658 | 0.072 | Alpha-mannosidase inhibitor | 0.072 0.016 DBMET03714 | DBMET03714 | |
| 0.006 | 0.66 | 0.173 | Psychostimulant | 0.173 0.098 DBMET03714 | DBMET03714 | |
| 0.005 | 0.662 | 0.243 | Histidine decarboxylase inhibitor | 0.243 0.009 DBMET03714 | DBMET03714 | |
| 0.003 | 0.661 | 0.159 | Acyl-CoA dehydrogenase inhibitor | 0.159 0.008 DBMET03714 | DBMET03714 | |
| 0.004 | 0.662 | 0.067 | Mannosidase inhibitor | 0.067 0.013 DBMET03714 | DBMET03714 | |
| 0.009 | 0.669 | 0.132 | Ornithine decarboxylase inhibitor | 0.132 0.018 DBMET03714 | DBMET03714 | |
| 0.005 | 0.665 | 0.057 | Membrane dipeptidase inhibitor | 0.057 0.012 DBMET03714 | DBMET03714 | |
| 0.005 | 0.666 | 0.111 | Catalase inhibitor | 0.111 0.035 DBMET03714 | DBMET03714 | |
| 0.006 | 0.67 | 0.036 | Retinoic acid alpha receptor agonist | 0.036 0.034 DBMET03713 | DBMET03713 | |
| 0.016 | 0.681 | 0.109 | HIV-1 integrase (Overall Integration) inhibitor | 0.109 0.047 DBMET03714 | DBMET03714 | |
| 0.013 | 0.677 | 0.139 | Glycine receptor agonist | 0.139 0.008 DBMET03714 | DBMET03714 | |
| 0.002 | 0.668 | 0.134 | Ornithine carbamoyltransferase inhibitor | 0.134 0.011 DBMET03714 | DBMET03714 | |
| 0.004 | 0.671 | 0.126 | Argininosuccinate synthase inhibitor | 0.126 0.014 DBMET03714 | DBMET03714 | |
| 0.004 | 0.673 | 0.04 | Carboxypeptidase B inhibitor | 0.04 0.013 DBMET03714 | DBMET03714 | |
| 0.003 | 0.673 | 0.099 | NMDA receptor glycine site agonist | 0.099 0.017 DBMET03714 | DBMET03714 | |
| 0.004 | 0.674 | 0.046 | Toll-Like receptor 2 agonist | 0.046 0.026 DBMET03714 | DBMET03714 | |
| 0.009 | 0.68 | 0.167 | Cystathionine beta-synthase inhibitor | 0.167 0.034 DBMET03714 | DBMET03714 | |
| 0.011 | 0.684 | 0.259 | Immunostimulant | 0.259 0.092 DBMET03714 | DBMET03714 | |
| 0.002 | 0.678 | 0.018 | Antibiotic Anthracycline-like | 0.018 0.014 DBMET03714 | DBMET03714 | |
| 0.007 | 0.685 | 0.139 | Calcium antagonist | 0.139 0.026 DBMET03714 | DBMET03714 | |
| 0.003 | 0.681 | 0.066 | Alpha 1d adrenoreceptor agonist | 0.066 0.008 DBMET03714 | DBMET03714 | |
| 0.004 | 0.683 | 0.136 | Biliverdin reductase inhibitor | 0.136 0.011 DBMET03714 | DBMET03714 | |
| 0.006 | 0.687 | 0.187 | Nitric-oxide synthase inhibitor | 0.187 0.012 DBMET03714 | DBMET03714 | |
| 0.018 | 0.706 | 0.117 | Cyclooxygenase 3 inhibitor | 0.117 0.081 DBMET03714 | DBMET03714 | |
| 0 | 0.692 | 0.014 | Lysophosphatidic acid receptor 3 agonist | 0.014 0.009 DBMET03714 | DBMET03714 | |
| 0.006 | 0.699 | 0.038 | Growth hormone release inhibitor | 0.038 0.034 DBMET03714 | DBMET03714 | |
| 0.012 | 0.705 | 0.222 | Glutamate dehydrogenase inhibitor | 0.222 0.008 DBMET03714 | DBMET03714 | |
| 0.002 | 0.696 | 0.065 | Geranyltranstransferase inhibitor | 0.065 0.01 DBMET03714 | DBMET03714 | |
| 0.005 | 0.702 | 0.061 | Carbonic anhydrase VA inhibitor | 0.061 0.059 DBMET03714 | DBMET03714 | |
| 0.002 | 0.7 | 0.049 | 5 Hydroxytryptamine 2 agonist | 0.049 0.04 DBMET03714 | DBMET03714 | |
| 0.001 | 0.701 | 0.037 | Uridine phosphorylase inhibitor | 0.037 0.013 DBMET03714 | DBMET03714 | |
| 0.015 | 0.715 | 0.151 | Antipruritic | 0.151 0.093 DBMET03714 | DBMET03714 | |
| 0.004 | 0.707 | 0.059 | Carbonic anhydrase V inhibitor | 0.059 0.055 DBMET03714 | DBMET03714 | |
| 0.002 | 0.707 | 0.032 | Glutamate (mGluR1a) agonist | 0.032 0.008 DBMET03714 | DBMET03714 | |
| 0.005 | 0.711 | 0.126 | Diuretic | 0.126 0.098 DBMET03714 | DBMET03714 | |
| 0.012 | 0.72 | 0.191 | Aminopeptidase B inhibitor | 0.191 0.023 DBMET03714 | DBMET03714 | |
| 0.023 | 0.732 | 0.063 | Calcium channel P-type blocker | 0.063 0.045 DBMET03714 | DBMET03714 | |
| 0.008 | 0.719 | 0.109 | GABA B receptor agonist | 0.109 0.011 DBMET03714 | DBMET03714 | |
| 0.012 | 0.723 | 0.107 | Sphingomyelinase inhibitor | 0.107 0.053 DBMET03714 | DBMET03714 | |
| 0.014 | 0.726 | 0.202 | Transcription factor NF kappa B inhibitor | 0.202 0.167 DBMET03714 | DBMET03714 | |
| 0.022 | 0.736 | 0.221 | Adenylate kinase inhibitor | 0.221 0.012 DBMET03714 | DBMET03714 | |
| 0.017 | 0.732 | 0.207 | Antithrombotic | 0.207 0.169 DBMET03714 | DBMET03714 | |
| 0.013 | 0.728 | 0.151 | Protein kinase stimulant | 0.151 0.068 DBMET03714 | DBMET03714 | |
| 0.006 | 0.726 | 0.081 | Potassium channel intermediate-conductance Ca-activated blocker | 0.081 0.017 DBMET03714 | DBMET03714 | |
| 0.003 | 0.723 | 0.027 | Lysophosphatidic acid receptor 1 agonist | 0.027 0.015 DBMET03714 | DBMET03714 | |
| 0.012 | 0.735 | 0.104 | Adenylate cyclase inhibitor | 0.104 0.081 DBMET03714 | DBMET03714 | |
| 0.005 | 0.73 | 0.061 | Adenylate cyclase 1 inhibitor | 0.061 0.017 DBMET03714 | DBMET03714 | |
| 0.004 | 0.729 | 0.051 | Squalene epoxidase inhibitor | 0.051 0.032 DBMET03714 | DBMET03714 | |
| 0.001 | 0.726 | 0.015 | Purinergic P2Y1 agonist | 0.015 0.012 DBMET03714 | DBMET03714 | |
| 0 | 0.728 | 0.03 | Carbonic anhydrase VIII inhibitor | 0.03 0.004 DBMET03714 | DBMET03714 | |
| 0 | 0.728 | 0.03 | Carbonic anhydrase X inhibitor | 0.03 0.004 DBMET03714 | DBMET03714 | |
| 0.008 | 0.737 | 0.052 | Glutamate (mGluR4) antagonist | 0.052 0.019 DBMET03714 | DBMET03714 | |
| 0.013 | 0.742 | 0.166 | Triose-phosphate isomerase inhibitor | 0.166 0.016 DBMET03714 | DBMET03714 | |
| 0.006 | 0.736 | 0.148 | Anticonvulsant | 0.148 0.132 DBMET03714 | DBMET03714 | |
| 0.019 | 0.749 | 0.127 | Vanilloid 1 agonist | 0.127 0.071 DBMET03714 | DBMET03714 | |
| 0.028 | 0.759 | 0.091 | CC chemokine 5 receptor agonist | 0.091 0.035 DBMET03714 | DBMET03714 | |
| 0.003 | 0.735 | 0.146 | Phosphofructokinase-1 inhibitor | 0.146 0.019 DBMET03714 | DBMET03714 | |
| 0.003 | 0.736 | 0.081 | 5 Hydroxytryptamine 2A agonist | 0.081 0.027 DBMET03714 | DBMET03714 | |
| 0.001 | 0.735 | 0.022 | Isoleucine-tRNA ligase inhibitor | 0.022 0.017 DBMET03714 | DBMET03714 | |
| 0.024 | 0.758 | 0.229 | Vasodilator, peripheral | 0.229 0.145 DBMET03714 | DBMET03714 | |
| 0.003 | 0.738 | 0.069 | GABA B receptor antagonist | 0.069 0.009 DBMET03714 | DBMET03714 | |
| 0.003 | 0.738 | 0.159 | Carbamoyl phosphate synthetase inhibitor | 0.159 0.01 DBMET03714 | DBMET03714 | |
| 0.012 | 0.747 | 0.238 | 5 Hydroxytryptamine 1E antagonist | 0.238 0.088 DBMET03714 | DBMET03714 | |
| 0.054 | 0.793 | 0.296 | Interleukin 2 agonist | 0.296 0.076 DBMET03714 | DBMET03714 | |
| 0 | 0.741 | 0.012 | Carbonic anhydrase XI inhibitor | 0.012 0.009 DBMET03714 | DBMET03714 | |
| 0.004 | 0.745 | 0.092 | Sphingosine 1-phosphate receptor 4 agonist | 0.092 0.029 DBMET03714 | DBMET03714 | |
| 0.005 | 0.747 | 0.119 | Expectorant | 0.119 0.051 DBMET03714 | DBMET03714 | |
| 0.006 | 0.753 | 0.119 | Mucolytic | 0.119 0.056 DBMET03714 | DBMET03714 | |
| 0.002 | 0.75 | 0.04 | Sphingosine 1-phosphate receptor 1 agonist | 0.04 0.032 DBMET03714 | DBMET03714 | |
| 0.001 | 0.75 | 0.057 | Fumarate hydratase inhibitor | 0.057 0.011 DBMET03714 | DBMET03714 | |
| 0.005 | 0.756 | 0.114 | NMDA receptor agonist | 0.114 0.015 DBMET03714 | DBMET03714 | |
| 0.004 | 0.756 | 0.179 | Inducible nitric-oxide synthase inhibitor | 0.179 0.011 DBMET03714 | DBMET03714 | |
| 0.002 | 0.756 | 0.093 | Dopamine D5 agonist | 0.093 0.005 DBMET03714 | DBMET03714 | |
| 0.005 | 0.761 | 0.084 | Glycine receptor antagonist | 0.084 0.051 DBMET03714 | DBMET03714 | |
| 0.003 | 0.759 | 0.182 | Glutamate decarboxylase inhibitor | 0.182 0.009 DBMET03714 | DBMET03714 | |
| 0.008 | 0.765 | 0.041 | Antibiotic Aminoglycoside-like | 0.041 0.02 DBMET03714 | DBMET03714 | |
| 0.019 | 0.776 | 0.15 | Interferon gamma antagonist | 0.15 0.078 DBMET03714 | DBMET03714 | |
| 0.006 | 0.763 | 0.043 | Phenylethanolamine N methyltransferase inhibitor | 0.043 0.024 DBMET03714 | DBMET03714 | |
| 0.006 | 0.766 | 0.056 | Ryanodine receptor antagonist | 0.056 0.049 DBMET03714 | DBMET03714 | |
| 0.001 | 0.76 | 0.019 | Telomerase stimulant | 0.019 0.009 DBMET03714 | DBMET03714 | |
| 0.003 | 0.764 | 0.053 | AMPA 4 receptor antagonist | 0.053 0.013 DBMET03714 | DBMET03714 | |
| 0.007 | 0.771 | 0.193 | Spasmolytic | 0.193 0.126 DBMET03714 | DBMET03714 | |
| 0.003 | 0.767 | 0.102 | Na+ K+ transporting ATPase inhibitor | 0.102 0.029 DBMET03714 | DBMET03714 | |
| 0.003 | 0.767 | 0.057 | Oxytocin agonist | 0.057 0.019 DBMET03714 | DBMET03714 | |
| 0.008 | 0.773 | 0.153 | Nav1.6 sodium channel blocker | 0.153 0.05 DBMET03714 | DBMET03714 | |
| 0.009 | 0.777 | 0.028 | Vasopressin 1A agonist | 0.028 0.023 DBMET03715 | DBMET03715 | |
| 0.052 | 0.821 | 0.394 | 5 Hydroxytryptamine uptake stimulant | 0.394 0.015 DBMET03714 | DBMET03714 | |
| 0.002 | 0.773 | 0.066 | Carbonic anhydrase VB inhibitor | 0.066 0.031 DBMET03714 | DBMET03714 | |
| 0.007 | 0.779 | 0.161 | Arachidonic acid antagonist | 0.161 0.076 DBMET03714 | DBMET03714 | |
| 0.003 | 0.784 | 0.042 | 5 Hydroxytryptamine 2B agonist | 0.042 0.022 DBMET03714 | DBMET03714 | |
| 0.015 | 0.798 | 0.225 | Cholesterol antagonist | 0.225 0.144 DBMET03714 | DBMET03714 | |
| 0.002 | 0.785 | 0.029 | Vanilloid 2 agonist | 0.029 0.011 DBMET03714 | DBMET03714 | |
| 0.006 | 0.79 | 0.055 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.055 0.011 DBMET03714 | DBMET03714 | |
| 0.032 | 0.816 | 0.227 | Growth hormone agonist | 0.227 0.05 DBMET03714 | DBMET03714 | |
| 0.03 | 0.817 | 0.159 | Ca2+-transporting ATPase inhibitor | 0.159 0.025 DBMET03714 | DBMET03714 | |
| 0.005 | 0.794 | 0.043 | Glutamate (mGluR group III) antagonist | 0.043 0.032 DBMET03714 | DBMET03714 | |
| 0.018 | 0.815 | 0.254 | RNA-directed DNA polymerase inhibitor | 0.254 0.047 DBMET03714 | DBMET03714 | |
| 0.005 | 0.804 | 0.155 | Sphingosine 1-phosphate receptor 2 antagonist | 0.155 0.035 DBMET03714 | DBMET03714 | |
| 0.005 | 0.805 | 0.054 | Glutamate (mGluR8) agonist | 0.054 0.009 DBMET03714 | DBMET03714 | |
| 0.009 | 0.811 | 0.154 | DOPA decarboxylase inhibitor | 0.154 0.019 DBMET03714 | DBMET03714 | |
| 0.006 | 0.809 | 0.141 | Acetylcholine M1 receptor antagonist | 0.141 0.083 DBMET03714 | DBMET03714 | |
| 0.03 | 0.834 | 0.256 | Sodium/bile acid cotransporter inhibitor | 0.256 0.122 DBMET03717 | DBMET03717 | |
| 0.003 | 0.808 | 0.023 | Glutamate (mGluR1) agonist | 0.023 0.02 DBMET03714 | DBMET03714 | |
| 0.01 | 0.817 | 0.126 | Sphingosine 1-phosphate receptor 4 antagonist | 0.126 0.062 DBMET03714 | DBMET03714 | |
| 0 | 0.824 | 0.012 | Glutamate (mGluR6) agonist | 0.012 0.008 DBMET03714 | DBMET03714 | |
| 0.002 | 0.826 | 0.039 | GABA uptake inhibitor | 0.039 0.027 DBMET03714 | DBMET03714 | |
| 0.001 | 0.828 | 0.055 | Arginase inhibitor | 0.055 0.012 DBMET03714 | DBMET03714 | |
| 0.01 | 0.84 | 0.147 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.147 0.027 DBMET03714 | DBMET03714 | |
| 0.002 | 0.834 | 0.061 | NMDA 2C receptor antagonist | 0.061 0.043 DBMET03714 | DBMET03714 | |
| 0.005 | 0.838 | 0.16 | Insulin sensitizer | 0.16 0.12 DBMET03714 | DBMET03714 | |
| 0.008 | 0.844 | 0.194 | Adenylate cyclase stimulant | 0.194 0.017 DBMET03714 | DBMET03714 | |
| 0.004 | 0.843 | 0.055 | Kainate receptor agonist | 0.055 0.01 DBMET03714 | DBMET03714 | |
| 0.007 | 0.847 | 0.158 | Sphingosine 1-phosphate receptor 5 antagonist | 0.158 0.049 DBMET03714 | DBMET03714 | |
| 0.008 | 0.85 | 0.12 | Anabolic | 0.12 0.039 DBMET03714 | DBMET03714 | |
| 0.014 | 0.857 | 0.106 | Amylase inhibitor | 0.106 0.091 DBMET03714 | DBMET03714 | |
| 0.007 | 0.858 | 0.091 | Glutamate (mGluR6) antagonist | 0.091 0.015 DBMET03714 | DBMET03714 | |
| 0.002 | 0.857 | 0.036 | Glutamate (mGluR3) agonist | 0.036 0.015 DBMET03714 | DBMET03714 | |
| 0.005 | 0.864 | 0.221 | Antibacterial | 0.221 0.206 DBMET03714 | DBMET03714 | |
| 0.003 | 0.867 | 0.117 | GABA aminotransferase inhibitor | 0.117 0.018 DBMET03714 | DBMET03714 | |
| 0.002 | 0.88 | 0.044 | Glutamate (mGluR3) antagonist | 0.044 0.017 DBMET03714 | DBMET03714 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |